Valve-forming ring, kit for valve-forming operation, and method for manufacturing valve-forming ring
The annuloplasty ring with a radiation-crosslinked hydrogel layer and rubber core addresses hemolysis and flexibility issues, enhancing surgical efficiency and patient outcomes by reducing hemolysis and allowing for valve annulus movement without excessive pressure.
Patent Information
- Application Number
- PCT/JP2024/018763
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-08-09
- Filing Date
- 2024-05-22
- Publication Date
- 2024-12-05
AI Technical Summary
Annuloplasty rings used in valvuloplasty procedures often cause hemolysis due to the collision of blood cells with the PET cloth, leading to increased surgical time and patient burden, and existing solutions like wrapping autologous pericardium around the ring increase surgical time and burden on both patient and doctor.
Development of an annuloplasty ring with a radiation-crosslinked hydrogel layer impregnated fabric, featuring a core with a second rubber layer and specific surface roughness, to reduce hemolysis and enhance flexibility, allowing the ring to follow valve annulus movement without excessive pressure.
The annuloplasty ring effectively suppresses hemolysis, reduces surgical time, and provides out-of-plane flexibility, minimizing the risk of valve stenosis and blood flow disturbance while maintaining structural integrity.
Smart Images

Figure JP2024018763_05122024_PF_FP_ABST
Abstract
Description
Annuloplasty ring, annuloplasty kit, and method for manufacturing annuloplasty ring
[0001] The present invention relates to an annuloplasty ring, an annuloplasty kit, and a method for manufacturing an annuloplasty ring.
[0002] In recent years, the number of cases of valvular heart disease treated in the field of cardiovascular surgery has been increasing due to the aging population. Valvular heart disease refers to a condition in which the valves do not function normally. Specific examples include stenosis, in which the valves do not move properly, obstructing blood flow, and insufficiency, in which the valves do not close completely, resulting in reverse blood flow. Mitral valve diseases, such as mitral regurgitation and mitral stenosis, and tricuspid valve diseases, such as tricuspid stenosis and tricuspid insufficiency, are generally treated with valve replacement, in which the valve itself is replaced with an artificial valve, or valvuloplasty, in which the patient's valve is left intact and reshaped. Currently, valvuloplasty is the most commonly used treatment. Furthermore, valvuloplasty is increasingly being performed in cases previously treated with valve replacement, such as those with rheumatic changes or infective endocarditis.
[0003] In valvuloplasty, annuloplasty rings are used to prevent re-expansion of the valve annulus after repairing damaged portions of the valve or chordae tendineae. Annuloplasty rings are generally constructed with a metal core, such as titanium, cobalt alloy, or nickel-titanium, silicone rubber, and a polyethylene terephthalate (PET) outermost layer (see, for example, Patent Documents 1 and 2).
[0004] Special table 2018-519895 Special table Hei 4-503318
[0005] Jpn. J. Cardiovasc. Surg. 37:151-154 (2008, Journal of Heart Valve Disease, 2005
[0006] One of the problems in valvuloplasty is that after valvuloplasty, the mitral valve regurgitant jet impinges on the annuloplasty ring, causing hemolysis and requiring reoperation. This is thought to be caused by red blood cells impinging on the PET fabric and exposing it to shear stress.
[0007] To address the above-mentioned issues, clinical trials have investigated a method for preventing hemolysis by wrapping the annuloplasty ring with autologous pericardium. However, this method requires harvesting the autologous pericardium, which increases the surgical time and burden on the patient and physician (Non-Patent Document 1). Therefore, there is a need for the development of an annuloplasty ring that can suppress hemolysis.
[0008] An object of the present invention is to provide an annuloplasty ring that can suppress hemolysis, for example.
[0009] The present invention has been made to solve the above problems and comprises the following aspects.
[0010] <First Aspect> [1] An annuloplasty ring comprising (1) a ring-shaped core and (2) a first layer covering the surface of the core and comprising a fabric or texture impregnated with a hydrogel, wherein the hydrogel is irradiated and crosslinked. [2] The annuloplasty ring according to [1], wherein (3) a second layer comprising rubber is present between the core and the first layer, and the ratio of the arithmetic mean roughness of the surface of the first layer that is not in contact with the core or the second layer to the arithmetic mean roughness of the back surface of the first layer that is in contact with the core or the second layer is 0.01 to 0.40. [3] The annuloplasty ring according to [1] or [2], wherein the first layer comprises an impregnated layer containing a fabric or material impregnated with hydrogel and a hydrogel layer made of hydrogel, wherein the ratio of the stress of the hydrogel layer before subjecting the hydrogel to a water absorption treatment to the stress of the hydrogel after subjecting the hydrogel to the water absorption treatment is 0.05 to 0.80, and the water absorption treatment is a treatment of leaving the hydrogel layer in a solution at 30°C to 50°C for 30 to 90 minutes. [4] The annuloplasty ring according to any one of [1] to [3], wherein the hydrogel is gelatin or collagen. [5] The annuloplasty ring according to any one of [1] to [4], wherein the irradiation in the irradiation crosslinking is at least one selected from the group consisting of X-ray irradiation, gamma-ray irradiation, electron beam irradiation, UV irradiation, and plasma irradiation. [6] The annuloplasty ring according to any one of [1] to [5], wherein the irradiation in the irradiation crosslinking is electron beam irradiation. [7] The annuloplasty ring according to any one of [1] to [6], wherein the fabric or material contains polyester fiber. [8] The annuloplasty ring according to any one of [1] to [7], wherein the hydrogel is further chemically crosslinked. [9] An annuloplasty ring comprising (1) a ring-shaped core and (2) a first layer comprising a fabric or material impregnated with hydrogel, which covers the surface of the core.
[10] The annuloplasty ring according to any one of [1] to [9], which is used to suppress hemolysis in annuloplasty.
[11] An annuloplasty kit comprising the annuloplasty ring according to any one of [1] to
[10] , and a holder and / or a sizer.
[12] A method for manufacturing an annuloplasty ring comprising (1) a ring-shaped core and (2) a first layer comprising a fabric or material impregnated with a hydrogel, the first layer covering the surface of the core, the method comprising a step of irradiating the annuloplasty ring with radiation.
[13] The method according to
[12] , wherein the step of irradiating with radiation is a step of irradiating with at least one selected from the group consisting of X-rays, gamma rays, electron beams, UV rays, and plasma.
[14] The method according to
[12] or
[13] , wherein the step of irradiating with radiation is a step of irradiating with an electron beam.
[15] The method according to any one of
[12] to
[14] , further comprising a step of adding a crosslinking agent.
[0011] <Second Aspect> The present invention also includes a second aspect described below. [1] An annuloplasty ring comprising (1) a ring-shaped core and (2) a first layer covering the surface of the core, the first layer comprising a fabric or texture impregnated with a hydrogel. [2] The annuloplasty ring according to [1], wherein (3) a second layer comprising rubber is present between the core and the first layer. [3] The annuloplasty ring according to claim 1, wherein the hydrogel is gelatin or collagen. [4] The annuloplasty ring according to any one of [1] to [3], wherein the fabric or texture comprises polyester fiber. [5] The annuloplasty ring according to any one of [1] to [4], wherein the hydrogel is chemically crosslinked. [6] The annuloplasty ring according to any one of [1] to [5], wherein the crosslinking agent for the chemical crosslinking is glutaraldehyde or glyoxal. [7] The annuloplasty ring according to any one of [1] to [6], wherein the ratio of the arithmetic mean roughness of the surface of the first layer that is not in contact with the core or the second layer to the arithmetic mean roughness of the back surface of the first layer that is in contact with the core or the second layer is 0.01 to 0.40. [8] The annuloplasty ring according to any one of [1] to [7], wherein the ratio is 0.02 to 0.25. [9] The annuloplasty ring according to any one of [1] to [8], wherein the ratio is 0.03 to 0.2.
[10] A kit for annuloplasty comprising the annuloplasty ring according to any one of [1] to [9], and a holder and / or a sizer.
[11] A method for producing an annuloplasty ring comprising (1) a ring-shaped core and (2) a first layer covering the surface of the core, the first layer comprising a fabric or material impregnated with a hydrogel, the method comprising the following steps: (Step 1) Step 1 of providing the fabric or material on the outside of the ring-shaped core to obtain a composite of the ring-shaped core and the fabric or material, (Step 2) Step 2 of contacting the composite with a hydrogel to obtain an impregnated composite impregnated with a hydrogel, and (Step 3) Step 3 of contacting the impregnated composite with a crosslinker.
[12] The method according to
[11] , wherein the hydrogel is gelatin or collagen.
[13] The method according to
[11] or
[12] , wherein step 2 is performed by fixing the complex on the central axis of a substantially cylindrical or substantially prismatic container containing a hydrogel.
[14] The method according to any one of
[11] to
[13] , wherein the crosslinking agent is glutaraldehyde or glyoxal.
[15] The method according to any one of
[11] to
[14] , wherein the concentration of the crosslinking agent is 0.01% to 0.7%.
[16] The method according to any one of
[11] to
[14] , wherein the concentration of the crosslinking agent is 0.04% to 0.6%.
[0012] The problems associated with the second aspect are described below. Because annuloplasty rings employ a rigid metal core as a component, the pressure of the core can excessively restrict the movement of the annulus. In such cases, there is a risk of valve stenosis or disruption of blood flow. To avoid these problems, an annuloplasty ring capable of following out-of-plane movement (i.e., having flexibility in the out-of-plane direction) is needed. To address the above issues, annuloplasty rings that follow the movement of the annulus have been proposed by optimizing the material and cross-sectional shape of the metal core. However, these annuloplasty rings have insufficient ability to follow large movements between the contracted and expanded states of the valve, and there is also a risk of a decrease in metal fatigue strength due to changes in the cross-sectional shape. Therefore, there is a need for an annuloplasty ring that can follow out-of-plane movement. A problem associated with the second aspect is to provide an annuloplasty ring that has flexibility in the out-of-plane direction. Furthermore, an effect of the second aspect can be, for example, providing an annuloplasty ring that has flexibility in the out-of-plane direction.
[0013] <Third Aspect> The present invention also includes a third aspect described below. [1] An annuloplasty ring comprising (1) a ring-shaped core and (2) a first layer circumferentially covering the surface of the core, the first layer comprising an impregnated layer containing a fabric or material impregnated with hydrogel and a hydrogel layer made of hydrogel. [2] The annuloplasty ring according to [1], wherein (3) a second layer containing rubber is present between the core and the first layer. [3] The annuloplasty ring according to [1] or [2], wherein the hydrogel is gelatin or collagen. [4] The annuloplasty ring according to any one of [1] to [3], wherein the fabric or material contains polyester fiber. [5] The annuloplasty ring according to any one of [1] to [4], wherein the hydrogel is chemically crosslinked. [6] The annuloplasty ring according to any one of [1] to [5], wherein the crosslinking agent for the chemical crosslinking is glutaraldehyde or glyoxal. [7] The annuloplasty ring according to any one of [1] to [6], wherein the ratio of the stress of the hydrogel in the hydrogel layer before subjecting the hydrogel to a water absorption treatment to the stress of the hydrogel after subjecting the hydrogel to the water absorption treatment is 0.05 to 0.80, and the water absorption treatment is a treatment of leaving the hydrogel layer in a solution at 30°C to 50°C for 30 to 90 minutes. [8] The annuloplasty ring according to any one of [1] to [7], wherein the ratio is 0.07 to 0.60. [9] The annuloplasty ring according to any one of [1] to [8], wherein the ratio is 0.07 to 0.50.
[10] A kit for valvuloplasty comprising the annuloplasty ring according to any one of [1] to [9], and a holder and / or a sizer.
[0014] The following describes the problems associated with the third aspect. In annuloplasty, annuloplasty rings are used after repairing damaged portions of the valve or chordae tendineae. Examples of such annuloplasty rings include those constructed of a rigid metal core, such as titanium, cobalt alloy, or nickel-titanium, with silicone rubber and a polyethylene terephthalate (PET) fabric at the outermost periphery (see, for example, Patent Documents 1 and 2, and U.S. Patent No. 6,805,711). Other examples include artificial valve rings that may include, as part of their components, a sheet combining a bioabsorbable thread and a hydrogel (see, for example, Japanese Patent No. 6,310,167). Annuloplasty rings such as those described in Patent Documents 1 and 2 and U.S. Patent No. 6,805,711 suffer from stability issues. Specifically, while the annuloplasty rings described above use a rigid metal core, repeated stress can cause damage to stress-concentrated areas due to fatigue (e.g., metal fatigue). The aforementioned Patent No. 6,310,167 primarily relates to a sheet combining a bioabsorbable thread and a hydrogel, and merely describes its applicability to artificial valve annuli. That is, it makes no mention of the specific configuration of an annuloplasty ring, and naturally, it does not address the above-mentioned problems. Therefore, simply applying the sheet of Patent No. 6,310,167 to an annuloplasty ring would clearly result in the above-mentioned problems. Therefore, there is a need for an annuloplasty ring that can overcome the stability issues described above, for example, an annuloplasty ring that can suppress stress concentration. A challenge related to the third aspect is to provide an annuloplasty ring that can suppress stress concentration (i.e., thereby reducing the possibility of failure due to stress concentration). Furthermore, an effect of the third aspect can be, for example, providing an annuloplasty ring that can reduce the possibility of failure due to stress concentration.
[0015] The annuloplasty ring of the present invention can, for example, suppress hemolysis.
[0016] Fig. 1 is a diagram showing the appearance of an annuloplasty ring. Fig. 2 is a diagram showing the layer structure of an annuloplasty ring. Fig. 3 is a diagram for explaining flexibility in the out-of-plane and in-plane directions of an annuloplasty ring. Fig. 4 is a diagram for explaining an outline of an in-plane tensile test used in calculating the von Mises stress. Fig. 5 is a diagram for explaining the radius of curvature of the core of an annuloplasty ring.
[0017] <Annuloplasty Ring of First Aspect of the Present Invention> The annuloplasty ring of the first aspect of the present invention comprises (1) a ring-shaped core, and (2) a first layer covering the surface of the core, the first layer comprising a fabric or material impregnated with a hydrogel, wherein the hydrogel is crosslinked by irradiation. Details of the annuloplasty ring of the first aspect of the present invention are described below.
[0018] As described above, annuloplasty rings are used to prevent re-enlargement of the valve annulus after annuloplasty for mitral valve diseases such as mitral regurgitation and mitral stenosis, and tricuspid valve diseases such as tricuspid stenosis and tricuspid insufficiency. Annuloplasty rings are also sometimes called annuloplasty rings, artificial valve annuli, annuloplasty bands, or annuloplasty bands. The annuloplasty ring of the present invention has an appearance as shown in FIG. 1 , for example. Reference numeral 1 in FIG. 1 corresponds to the annuloplasty ring of the present invention. Furthermore, the annuloplasty ring of the present invention includes, for example, a core, a first layer, and a second layer according to the present invention, as described below, and their positional relationship is shown in FIG. 2 . FIG. 2 shows the cross-sectional structure of the annuloplasty ring of the present invention, disclosing the core 2 according to the present invention, the first layer 4 according to the present invention, and the second layer 3 according to the present invention.
[0019] The annuloplasty ring of the present invention is adapted to be implanted into, for example, the mitral valve annulus or tricuspid valve annulus. Therefore, the annuloplasty ring of the present invention preferably has a shape similar to the shape of, for example, the mitral valve annulus or tricuspid valve annulus. Specifically, the shape may be a complete ring shape (also called a full ring) that surrounds the entire circumference of the annulus, or a partial ring shape with a notch in a portion of the annulus. More specifically, examples include an elliptical shape, a C-shape, a D-shape, a kidney-shape, a kidney bean-shape, and an egg-shape. The annuloplasty rings that are rigid rings and semi-rigid rings described below typically have a kidney-shape or a D-shape that conforms to the peripheral shape of the mitral valve annulus (see, for example, JP 2018-519986 A). The annuloplasty ring of the present invention may be bilaterally symmetrical or bilaterally asymmetrical. The annuloplasty ring of the present invention is preferably flat or saddle-shaped. In particular, the saddle-shaped ring more closely reflects the anatomical structure of the native mitral valve annulus than a flat ring, allowing for a natural annular shape, distributing the load on the annulus and minimizing the load transmitted to the valve leaflets and chordae tendineae. Furthermore, the annuloplasty ring of the present invention may be a flexible ring, a rigid ring, or a semi-rigid ring, with the semi-rigid ring being preferred. This is because a flexible ring may be too flexible and may not adequately remodel the annulus, while a rigid ring may not be able to follow the movement of the annulus. Therefore, a semi-rigid ring, which possesses both flexibility and rigidity, is the most preferred embodiment.
[0020] For example, by using the annuloplasty ring of the present invention in the above-described shape, it is possible to reduce the annular diameter and increase the coaptation area between the anterior and posterior leaflets. This is effective in preventing re-enlargement of the annulus and preventing tissue damage to the coaptation line of the leaflets, and is also effective in preventing the recurrence of mitral regurgitation. Furthermore, because suture dehiscence, which causes postoperative mitral regurgitation, is more likely to occur near the annulus than on the left ventricular side of the leaflet, annuloplasty using an annuloplasty ring also reinforces the sutures near the annulus. Furthermore, because the mitral annulus is corrected to its normal shape during systole, remodeling is expected to be effective in preventing the recurrence of mitral regurgitation.
[0021] [Core According to the First Aspect of the Present Invention] The core according to the first aspect of the present invention is a core that shapes the annuloplasty ring of the present invention, which can surround a valve annulus such as a mitral annulus or a tricuspid annulus. The core according to the first aspect of the present invention has a ring-like shape, and more specifically, a shape corresponding to the shape of the annuloplasty ring of the present invention described above. The cross-sectional shape of the core according to the first aspect of the present invention may be circular, rectangular, or have a layered structure.
[0022] Examples of materials for the core according to the first aspect of the present invention include metals, such as Nitinol (nickel-titanium, sometimes referred to as a titanium-nickel alloy), Elgiloy (cobalt-chromium-nickel alloy), alloys primarily composed of nickel, cobalt, chromium, and molybdenum, and stainless steel. Among these, Nitinol, Elgiloy, or stainless steel, which are semi-rigid materials possessing flexibility and rigidity, are preferred. More preferred are superelastic materials, such as Nitinol or similar superelastic alloys. Here, the term "superelasticity" (also referred to as "pseudoelasticity") refers to the elastic (reversible) response to applied stress caused by a phase transformation between the austenite and martensite phases of the crystal. Superelasticity allows a material, such as a metal alloy, to bend beyond what would conventionally be expected from that type of material (see U.S. Pat. No. 1,554,015).
[0023] Although the core according to the first aspect of the present invention is made of the above-described metal, it may be partially flexible. For example, the flexibility can be adjusted by changing the number of layers in the core in that portion, changing the thickness of at least one core cross-section in that portion, incorporating at least one core material made of a different material, or any combination thereof. The flexibility can also be adjusted by inserting a spacer (e.g., a polymer spacer and / or an elastomeric spacer) between at least one pair of adjacent core layers. Another embodiment includes a braided core made of multiple wires, strands, and / or braids (see, for example, JP 2018-519986 A).
[0024] The size of the core according to the first aspect of the present invention can be appropriately set depending on the patient to whom the annuloplasty ring of the present invention is to be applied, and when the cross section is circular, the diameter is, for example, 300 to 1500 micrometers, and when the cross section is polygonal (e.g., rectangular), the width is, for example, 300 to 1500 micrometers and the height is, for example, 300 to 1500 micrometers. Furthermore, when the core has a laminated structure, the structure is, for example, 2 to 8 plates each having a width of 300 to 3000 micrometers and a height of 30 to 1000 micrometers stacked together.
[0025] The core according to the first aspect of the present invention may have a predetermined radius of curvature. Specifically, for example, as shown in FIG. 5 , the core may have a first radius of curvature R represented by the posterior apex R of the core and / or an anterior apex r of the core. Specific examples of the value of the radius of curvature R are 12 to 30, and specific examples of the value of the radius of curvature r are 0.5 to 65. Regarding the method for calculating the radius of curvature, reference can be made to a method commonly known in this field. Furthermore, the calculation may be performed with reference to, for example, US 2023 / 0125047. The terms posterior apex and anterior apex are interpreted as they are commonly used in this field.
[0026] [First Layer According to the First Aspect of the Present Invention] The first layer according to the first aspect of the present invention covers the surface of the core according to the first aspect of the present invention and comprises a fabric or cloth impregnated with a hydrogel, wherein the hydrogel is crosslinked by irradiation.
[0027] The fabric or cloth in the first layer according to the first aspect of the present invention covers the surface of the core according to the first aspect of the present invention, and may cover either a portion of the core or the entire core according to the first aspect of the present invention. The fabric or cloth is preferably biocompatible, and specific examples include biocompatible knitted fabrics and woven fabrics. Various warp and weft knitting structures can be used as the knitted fabric, and particularly preferred examples include double raschel knitted fabrics, plain knitted fabrics, rib knitted fabrics, tricot fabrics, and raschel fabrics. For example, the warp knitted fabric (in a state in which the bioabsorbable material has not been decomposed and absorbed) preferably has a density of 20 courses / inch to 200 courses / inch and 20 wales / inch to 55 wales / inch. From the viewpoints of ease of suturing the fabric to biological tissue, water resistance, pinhole leakage, and anisotropy of the warp knitted fabric, the fineness is more preferably 70 to 110 courses / inch and 30 to 45 wales / inch, and even more preferably 80 to 100 courses / inch and 32 to 42 wales / inch. Plain weave, twill weave, and satin weave can be used as the woven fabric.
[0028] The fabric or cloth in the first layer according to the first aspect of the present invention is preferably composed of threads made of bioabsorbable and / or non-bioabsorbable materials. The bioabsorbable threads are not particularly limited as long as they are biocompatible and decompose, absorb, or disappear over time in the body. Specific examples include polyglycolic acid, polylactic acid, poly(lactide-glycolide) copolymer, polycyclic acid, polydioxanone, polycaprolactone, polyhydroxyalkanoate, modified polyvinyl alcohol, casein, modified starch, polyglactin-polycaprolactone copolymer, polyglycolic acid-lactic acid copolymer, and derivatives thereof. Among these, it is preferable to use at least one selected from the group consisting of polylactic acid, polydioxanone, polyglycolic acid, polyglactin-polycaprolactone copolymer, and polyglycolic acid-lactic acid copolymer. In this case, the threads have excellent versatility and strength and can be efficiently decomposed and absorbed in the body.
[0029] The non-bioabsorbable material is not particularly limited as long as it is biocompatible and does not decompose, absorb, or disappear in the body over time. Specific examples include fluorine fibers, nylon fibers, polyethylene terephthalate, polytrimethylene terephthalate, polybutylene terephthalate, polylactic acid, stereocomplex polylactic acid, polyester fibers such as polyester copolymerized with a third component, acrylic fibers, vinylon fibers, vinylidene fibers, polyvinyl chloride fibers, polyethylene fibers, polypropylene fibers, polyurethane fibers, carbon fibers, polystyrene fibers, and polymethyl methacrylate. Among these, it is preferable to use at least one fiber selected from the group consisting of fluorine fibers, nylon fibers, polyester fibers, and polypropylene fibers. In this case, the material has excellent versatility and strength, and can maintain sufficient strength as a fabric or cloth.
[0030] The thread made of the non-bioabsorbable material described above preferably has a total fineness of 22 dtex to 110 dtex, a single fiber fineness of 0.8 dtex to 5.0 dtex, and a filament count of 1 to 48. By adjusting the thread within the above ranges, it is possible to maintain sufficient strength while being lightweight. More preferably, the total fineness is 25 dtex to 50 dtex, the single fiber fineness is preferably 1 dtex to 5 dtex, and the filament count is preferably 5 to 20.
[0031] The thread made of the above-mentioned bioabsorbable material preferably has a total fineness of 20 dtex to 200 dtex, a single fiber fineness of 1.3 dtex to 44 dtex, and a filament count of 1 to 24. By adjusting the thread within the above ranges, it can be decomposed and absorbed in the body. More preferably, the total fineness is 25 dtex to 50 dtex, the single fiber fineness is preferably 1 dtex to 5 dtex, and the filament count is preferably 5 to 20.
[0032] The above-mentioned yarn made of a bioabsorbable material and / or yarn made of a non-bioabsorbable material may be monofilament or multifilament. In the case of multifilament, a soft texture can be achieved. Furthermore, when multifilament is used in vivo, cellular tissues are more likely to penetrate between the single filaments, which is preferable in terms of tissue regeneration. On the other hand, monofilament yarn has higher cleaning efficiency than multifilament. In the case of multifilament, the yarn made of a bioabsorbable material and / or yarn made of a non-bioabsorbable material preferably has 5 to 20 filaments and a total fineness of 25 dtex to 50 dtex.
[0033] The fabric or texture of the first layer according to the first aspect of the present invention is impregnated with a hydrogel, which may include, for example, gelatin, collagen, polyvinyl alcohol, polyacrylamide, poly-N-vinylpyrrolidone, poly(hydroxyethyl methacrylate), polyethylene oxide, polyethylene glycol, polyethylene glycol monomethyl ether, cellulose, polyacrylate, polymethacrylate, polymethyl acrylate, polylactic acid, polyvinyl sulfonic acid, polyamide, poly(L-lysine), hydrophilic polyurethane, maleic anhydride polymer, protein, fibrin, collagen, cellulosic polymer, methylcellulose, carboxymethylcellulose, dextran, carboxymethyl dextran, modified dextran, alginate, alginic acid, pectinic acid, hyaluronic acid, chitin, pullulan, elastin, laminin, agarose, gellan, xanthan, carboxymethyl starch, chondroitin sulfate, guar, starch, and copolymers, mixtures, and derivatives thereof. Among these, gelatin or collagen is preferred, and gelatin is more preferred.
[0034] The raw material for the gelatin can be, for example, a single molecular chain obtained by loosening the triple helix of collagen derived from bovine bone, bovine hide, pigskin, bird, or fish. Methods for producing such gelatin raw materials include acid treatment and alkali treatment (or lime treatment), and gelatin raw materials produced by either method may be used, or commercially available gelatin raw materials may also be used. Furthermore, commercially available gelatin raw materials undergo various purification steps before extraction during their production process, and therefore contain few components other than protein. Generally, they have a composition of 85% or more protein, 8 to 14% water, 2% or less ash, and 1% or less other components (lipids, polysaccharides, etc.). Such common gelatin raw materials can also be used in the present invention.
[0035] Because gelatin raw materials are thermally denatured collagens, their amino acid composition is nearly identical to that of collagen. However, compared to other proteins, they are highly specific, with glycine accounting for approximately one-third of the total and one-third of the amino acid repeats. Collagen and gelatin can be distinguished, for example, by observing the 31.5-degree signal obtained by wide-angle X-ray measurement. This 31.5-degree signal is derived from the triple helix structure of collagen, and disappears when the triple helix structure characteristic of collagen unravels to form gelatin. The content of gelatin raw materials in a gelatin solution is preferably 1% to 70% by weight, and more preferably 3% to 20% by weight. The solvent used to dissolve the gelatin raw materials is water, but (polyhydric) alcohols, dimethyl sulfoxide, etc. may be added as needed to adjust viscosity.
[0036] The hydrogel impregnation method for the fabric or substrate of the first layer according to the first aspect of the present invention can be carried out by methods commonly used in this field, such as spraying or applying the hydrogel to the fabric or substrate. More specifically, the method involves "impregnating the fabric or substrate with a solution containing the hydrogel (e.g., B-Matrix Gelatin LS-H manufactured by Nitta Gelatin) and repeatedly cooling or drying at a predetermined temperature." In this method, the temperature of the hydrogel solution is, for example, 20°C to 80°C, and the impregnation time is, for example, several seconds to several minutes. The cooling or drying time after impregnation is, for example, 2 minutes to 24 hours. Furthermore, for example, when the hydrogel is a protein, the amount of hydrogel coated on the fabric or material (mass of solids per area) is typically 1 mg / cm to 200 mg / cm, preferably 1 mg / cm to 100 mg / cm, more preferably 2 mg / cm to 80 mg / cm, and even more preferably 2 to 60 mg / cm.
[0037] In the fabric or texture of the first layer according to the first aspect of the present invention, the hydrogel is cross-linked by irradiation. The phrase "cross-linked by irradiation" means that the hydrogel is cross-linked by irradiation, as described below. Examples of the radiation used in the cross-linking by irradiation include X-ray irradiation, gamma-ray irradiation, electron beam irradiation, UV irradiation, and plasma irradiation. Among these, electron beam irradiation is preferred from the viewpoint of hemolysis rate. Regarding the radiation used in the cross-linking by irradiation, only one of the above-mentioned types of radiation may be used, or multiple types of radiation may be used in combination. A specific example of a combination of multiple types of radiation may include a first irradiation with radiation (e.g., UV irradiation) that results in a low degree of cross-linking, followed by a second irradiation with radiation (e.g., electron beam irradiation) that results in a high degree of cross-linking. This configuration allows for the production of an annuloplasty ring with higher strength.
[0038] The irradiation conditions for the radiation irradiation in the above-mentioned irradiation and crosslinking are preferably an acceleration voltage of 10 kV to 8,000 kV and an irradiation dose of 5 kGy to 200 kGy, more preferably 10 kGy to 60 kGy, and even more preferably 20 to 40 kGy. The radiation irradiation time can be adjusted as appropriate. The temperature during radiation irradiation is usually -80°C to 40°C and can be adjusted as appropriate. Furthermore, irradiation may be carried out in the presence of a desiccant or an oxygen scavenger, which can suppress the generation of ozone and prevent the radicals generated by electron beam irradiation from being deactivated by oxygen in the atmosphere.
[0039] The specific method of irradiating with radiation may be any method commonly used in this field (see, for example, JP 2020-157516 A, JP 2021-146242 A, etc.), and may be, for example, irradiating the first layer according to the first aspect of the present invention impregnated with hydrogel, under the following conditions: However, the following is an example and is not intended to be limiting. Irradiation device: electron beam irradiation device (e.g., Dynamitron electron accelerator manufactured by RDI) Dose measurement device: CTA dosimeter device (e.g., UV1800 spectrophotometer manufactured by Shimadzu) Dosimeter: CTA dosimeter (e.g., FTR-125 manufactured by Fujifilm) Acceleration voltage: 4.8 megavolts Current: 20 milliamperes Cart speed (circumference): 18.0 m / min Irradiation dose: 30 kilograys Irradiation direction: one side Number of irradiations: 2 Support material: laminated cardboard
[0040] The degree of crosslinking (degree of decomposition, decomposition rate) of the above-described irradiation-crosslinked hydrogel may be evaluated, for example, using the absorbance before and after irradiation as an index. This is a method that focuses on the phenomenon that absorbance increases as hydrogel decomposition progresses, and is commonly used in this field. Specifically, the absorbance when the hydrogel is completely decomposed and the absorbance after a certain period of time are measured, and the decomposition rate of the hydrogel is calculated from the ratio of these values. Based on this, the decomposition rate of the hydrogel before radiation irradiation and the decomposition rate of the hydrogel after radiation irradiation are calculated, and the ratio of these values (decomposition rate of the hydrogel after radiation irradiation / decomposition rate of the hydrogel before radiation irradiation) is further calculated.
[0041] As described above, the annuloplasty ring according to the first aspect of the present invention uses a radiation-crosslinked hydrogel as one of its constituent elements, and surprisingly, by adopting such a configuration, it is possible to suppress hemolysis, as will be apparent from the description of the examples below.
[0042] In the fabric or textile for the first layer according to the first aspect of the present invention, the hydrogel may be further chemically crosslinked. The phrase "the hydrogel may be chemically crosslinked" means that the hydrogel is crosslinked using a crosslinking agent, which will be described later. Examples of crosslinking agents for the chemical crosslinking include aldehyde-based crosslinking agents (glutaraldehyde, formaldehyde, glyoxal, etc.), isocyanate-based crosslinking agents (hexamethylene diisocyanate, etc.), carbozide-based crosslinking agents (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, etc.), polyepoxy-based crosslinking agents (ethylene glycol diethyl ether, etc.), and transglutaminase. Aldehyde-based crosslinking agents are preferred, glutaraldehyde or glyoxal are more preferred, and glutaraldehyde is particularly preferred.
[0043] The method for chemically crosslinking the hydrogel in the fabric or textile for the first layer according to the first aspect of the present invention may be any method commonly used in this field. For example, the first layer according to the first aspect of the present invention, impregnated with the hydrogel, may be immersed in a solution containing a crosslinking agent (e.g., Tokyo Chemical Industry Co., Ltd.'s 50% glutaraldehyde solution). The reaction time for impregnation in the solution containing the crosslinking agent is typically 30 minutes to 24 hours and can be adjusted as appropriate. The temperature during impregnation is typically 0°C to 50°C and can be adjusted as appropriate. Furthermore, the concentration of the crosslinking agent in the chemical crosslinking is typically 0.01% to 10% by mass.
[0044] The thickness of the first layer according to the first aspect of the present invention can be appropriately set depending on the patient to whom the annuloplasty ring of the present invention is to be applied, and is, for example, 100 micrometers to 2000 micrometers, preferably 150 micrometers to 1700 micrometers, and more preferably 200 micrometers to 1500 micrometers.
[0045] The annuloplasty ring of the present invention may include a second layer containing rubber (hereinafter, sometimes abbreviated as the second layer according to the first aspect of the present invention) in addition to the core and first layer according to the first aspect of the present invention. The second layer according to the first aspect of the present invention contains a rubber as described below and is positioned between the core according to the first aspect of the present invention and the first layer according to the first aspect of the present invention. Examples of rubber in the second layer according to the first aspect of the present invention include silicone rubber, latex rubber, synthetic rubber such as styrene-butadiene-styrene (SBS), styrene-isoprene-styrene (SIS), styrene-ethylene-butylene-styrene (SEBS), and styrene-ethylene-propylene-styrene (SEPS), fluorinated silicone rubber, fluororubber, chloroprene rubber, nitrile rubber, acrylic rubber, epichlorohydrin rubber, isoprene rubber, styrene-butadiene rubber, butadiene rubber, ethylene-propylene rubber, chlorinated polyethylene rubber, chlorosulfonated polyethylene rubber, and butyl rubber. Among these, silicone rubber is preferred. The rubber may be one that can be sewn with a suture.
[0046] The thickness of the second layer according to the first aspect of the present invention can be appropriately set depending on the patient to whom the annuloplasty ring according to the first aspect of the present invention is to be applied, and is, for example, 50 micrometers to 1500 micrometers.
[0047] The annuloplasty ring according to the first aspect of the present invention may be configured such that "(3) a second layer containing rubber is present between the core and the first layer, and the ratio of the arithmetic mean roughness of the surface of the first layer that is not in contact with the core or the second layer to the arithmetic mean roughness of the back surface of the first layer that is in contact with the core or the second layer is 0.01 to 0.40." Specific examples and preferred examples of this aspect can be found in the page regarding the annuloplasty ring according to the second aspect of the present invention described below.
[0048] The annuloplasty ring according to the first aspect of the present invention may be configured such that "the first layer includes an impregnated layer containing a fabric or material impregnated with hydrogel, and a hydrogel layer made of hydrogel, the ratio of the stress of the hydrogel layer before subjecting the hydrogel to a water absorption treatment to the stress of the hydrogel after subjecting the hydrogel to the water absorption treatment is 0.05 to 0.80, and the water absorption treatment is a treatment in which the hydrogel layer is left in a solution at 30°C to 50°C for 30 to 90 minutes." Specific examples and preferred examples of this aspect can be found in the page regarding the annuloplasty ring according to the third aspect of the present invention, which will be described later.
[0049] <Method for Manufacturing an Annuloplasty Ring of the First Aspect of the Present Invention> The method for manufacturing an annuloplasty ring of the present invention (hereinafter sometimes abbreviated as the manufacturing method of the first aspect of the present invention) is a method for manufacturing an annuloplasty ring comprising the above-mentioned (1) ring-shaped core and (2) a first layer comprising a fabric or material impregnated with a hydrogel, which covers the surface of the core, and includes a step of irradiating the annuloplasty ring with radiation (hereinafter sometimes abbreviated as the irradiation step of the present invention). The annuloplasty ring to be manufactured by the manufacturing method of the present invention is as described above.
[0050] More specifically, the manufacturing method of the present invention includes a step of preparing a core according to the first aspect of the present invention (hereinafter, sometimes abbreviated as a core preparation step according to the present invention), a step of preparing a first layer according to the first aspect of the present invention (hereinafter, sometimes abbreviated as a first layer preparation step according to the present invention), and an irradiation step according to the present invention.
[0051] The core preparation step according to the present invention is for preparing the core according to the first aspect of the present invention. Specifically, for example, a commercially available stainless steel ring (e.g., stainless steel ring manufactured by Maruho Hatsujo Kogyo) is prepared and, if necessary, adjusted to a desired size. The core itself according to the first aspect of the present invention is as described above in the section on the annuloplasty ring according to the first aspect of the present invention, and specific examples and preferred examples thereof are also the same.
[0052] The first layer preparation step according to the present invention is a step for preparing the first layer according to the first aspect of the present invention. A specific example is a method for preparing a fabric or cloth impregnated with a hydrogel. More specifically, the first layer according to the first aspect of the present invention is wrapped around the core according to the first aspect of the present invention or the second layer according to the first aspect of the present invention, and then sewn or simply placed over the core or the second layer. The suturing method may be any method commonly used in this field, such as hand sewing or suturing using a sewing machine or other machine. The first layer according to the first aspect of the present invention itself is as described above in the section on the annuloplasty ring according to the first aspect of the present invention, and the same applies to specific examples, preferred examples, etc.
[0053] The irradiation step according to the present invention is a step of irradiating radiation onto an annuloplasty ring comprising the core according to the first aspect of the present invention and the first layer according to the first aspect of the present invention, which are obtained by the core preparation step and the first layer preparation step according to the present invention. By carrying out this step, the hydrogel in the annuloplasty ring according to the first aspect of the present invention is irradiated and crosslinked. The type of radiation, the irradiation method, etc. are as explained above in the section regarding the annuloplasty ring according to the first aspect of the present invention, and specific examples, preferred examples, etc. are also the same.
[0054] The manufacturing method of the present invention may further include a step of adding a crosslinking agent to the annuloplasty ring, which includes the core according to the first aspect of the present invention and the first layer according to the first aspect of the present invention, obtained by the core preparation step and the first layer preparation step according to the present invention (hereinafter, this step may be abbreviated as the crosslinking agent addition step according to the present invention). By carrying out this step, the hydrogel in the annuloplasty ring of the present invention is chemically crosslinked. The type of crosslinking agent and the crosslinking method thereof are as described above in the section on the annuloplasty ring of the first aspect of the present invention, and specific examples and preferred examples thereof are also the same. Furthermore, the crosslinking agent addition step according to the present invention is preferably carried out (1) after the first layer preparation step according to the present invention and before the irradiation step according to the present invention, or (2) after the irradiation step according to the present invention.
[0055] The manufacturing method of the present invention may further include a step of preparing the second layer according to the first aspect of the present invention (sometimes abbreviated as the second layer preparation step according to the present invention). The second layer preparation step according to the present invention is for preparing the second layer according to the first aspect of the present invention described above. Specific examples include a method of preparing a rubber-containing second layer between the core according to the first aspect of the present invention and the first layer according to the first aspect of the present invention. Specific examples include a method of covering the core according to the first aspect of the present invention with the second layer according to the first aspect of the present invention and sealing both ends with liquid silicone or the like, or a method of preparing a mold larger than the core according to the first aspect of the present invention, inserting the core according to the first aspect of the present invention and the second layer according to the first aspect of the present invention into the mold, and molding them integrally. The second layer according to the first aspect of the present invention itself is as described above in the section on the annuloplasty ring according to the first aspect of the present invention, and specific examples and preferred examples thereof are also the same. The second layer preparation step according to the present invention is preferably performed after the core preparation step according to the present invention and before the first layer preparation step according to the present invention.
[0056] <Valvuloplasty Kit of the First Aspect of the Present Invention> The valvuloplasty kit of the first aspect of the present invention (hereinafter sometimes abbreviated as the kit of the first aspect of the present invention) includes the annuloplasty ring of the first aspect of the present invention and a holder and / or a sizer. The annuloplasty ring of the first aspect of the present invention is as described above in the annuloplasty ring of the first aspect of the present invention. The holder included in the kit of the first aspect of the present invention stores the annuloplasty ring of the first aspect of the present invention. By using the holder, a medical professional such as a physician can carry the annuloplasty ring of the first aspect of the present invention to a predetermined position in a patient. Furthermore, the sizer included in the kit of the first aspect of the present invention is a surgical instrument used manually during annuloplasty to measure the opening into which the annuloplasty ring is to be implanted.
[0057] The kit according to the first aspect of the present invention may contain instructions, if necessary. Such instructions substantially describe the principles, features, operating procedures, etc. of the annuloplasty ring according to the first aspect of the present invention through text, drawings, etc., and may take the form of an instruction manual, package insert, pamphlet, leaflet, etc.
[0058] The kit of the first aspect of the present invention is used in valvuloplasty for mitral valve diseases such as mitral regurgitation and mitral stenosis, and tricuspid valve diseases such as tricuspid stenosis and tricuspid insufficiency. Use of the kit of the first aspect of the present invention makes it possible to perform valvuloplasty simply, quickly, and accurately.
[0059] <Annuloplasty Ring of Second Aspect of the Present Invention> The annuloplasty ring of the second aspect of the present invention is characterized by including (1) a ring-shaped core and (2) a first layer covering the surface of the core, the first layer including a fabric or material impregnated with a hydrogel. Details of the annuloplasty ring of the second aspect of the present invention are described below.
[0060] [Core According to the Second Aspect of the Present Invention] Specific examples and preferred examples of the core according to the second aspect of the present invention can be found in the page on the core according to the first aspect of the present invention.
[0061] [First Layer According to the Second Aspect of the Present Invention] Specific examples, preferred examples, etc. of the first layer according to the second aspect of the present invention can be found in the page on the first layer according to the first aspect of the present invention described above.
[0062] [Second Layer According to the Second Aspect of the Present Invention] For specific examples and preferred examples of the second layer according to the second aspect of the present invention, please refer to the page on the second layer according to the first aspect of the present invention described above.
[0063] [Arithmetic Mean Roughness According to the Second Aspect of the Present Invention] The annuloplasty ring according to the second aspect of the present invention has the above-described structure, and the ratio of the arithmetic mean roughness of the surface of the first layer according to the second aspect of the present invention, which is not in contact with the core or second layer according to the second aspect of the present invention, to the arithmetic mean roughness of the back surface of the first layer according to the second aspect of the present invention, which is in contact with the core or second layer according to the second aspect of the present invention, is, for example, 0.01 to 0.40, preferably 0.02 to 0.25, more preferably 0.03 to 0.2, and particularly preferably 0.04 to 0.15. The arithmetic mean roughness represents the average distance from a reference line, where the average value of the surface irregularities is taken as a reference line. Therefore, the smaller the arithmetic mean roughness, the less irregularities there are and the smoother the surface is. As shown in the examples below, it has surprisingly been found that the annuloplasty ring according to the second aspect of the present invention has improved flexibility in the out-of-plane direction by setting the above-described specific arithmetic mean roughness ratio. Therefore, the annuloplasty ring of the second aspect of the present invention preferably has the above-mentioned specific arithmetic mean roughness ratio. The flexibility in the out-of-plane direction refers to the flexibility (degree of expansion) of the annuloplasty ring in the Z-axis direction, as shown in Fig. 3. Fig. 3 is intended to explain the flexibility of the annuloplasty ring 1, and the flexibility in the out-of-plane direction refers to the flexibility (degree of expansion) in the direction of arrow 5. On the other hand, the flexibility in the in-plane direction, which is the antonym of the "flexibility in the out-of-plane direction," refers to the flexibility (degree of expansion) in the direction of arrow 6.
[0064] The arithmetic mean roughness may be measured by a method commonly used in this field. For example, the annuloplasty ring according to the second aspect of the present invention may be fixed on a surface plate parallel to the ground, and measurement may be performed using a measuring device (for example, a one-shot 3D shape measuring device (VR-6000, manufactured by Keyence)) under the following conditions. Note that the following conditions are examples and are not limited to these. The location for measuring the arithmetic mean roughness may be the entire annuloplasty ring, or a portion thereof (for example, an arbitrary cut-out area of about 4 mm; for example, both ends or the center when the annuloplasty ring is straightened). For other detailed measurement methods, the contents of the examples described below may also be referred to. Roughness standard: JIS B 0601:1994, 2001 Cut-off value: 0.8 mm Reference value: 4 mm
[0065] The above-mentioned arithmetic mean roughness ratio is calculated using the following formula: <Formula 1> Arithmetic mean roughness ratio value = arithmetic mean roughness value of the front surface of the first layer according to the second aspect of the present invention / arithmetic mean roughness value of the back surface of the first layer according to the second aspect of the present invention
[0066] Regarding the configurations, materials, characteristics, etc. of the annuloplasty ring of the second aspect of the present invention, reference can be made to the items described for the annuloplasty ring of the first aspect of the present invention as appropriate.
[0067] <Method of Manufacturing an Annuloplasty Ring According to the Second Aspect of the Present Invention> The method of manufacturing an annuloplasty ring according to the second aspect of the present invention (hereinafter sometimes abbreviated as the manufacturing method of the second aspect of the present invention) is a method of manufacturing an annuloplasty ring comprising the above-described (1) ring-shaped core and (2) a first layer covering the surface of the core, the first layer comprising a fabric or material impregnated with a hydrogel, and includes the following steps: Step 1 (hereinafter sometimes abbreviated as step 1 according to the second aspect of the present invention) of providing the fabric or material on the outside of the ring-shaped core to obtain a composite of the ring-shaped core and the fabric or material; Step 2 (hereinafter sometimes abbreviated as step 2 according to the second aspect of the present invention) of contacting the composite with a hydrogel to obtain an impregnated composite impregnated with a hydrogel; and Step 3 (hereinafter sometimes abbreviated as step 3 according to the second aspect of the present invention) of contacting the impregnated composite with a crosslinking agent. It goes without saying that the annuloplasty ring manufactured by the manufacturing method of the second aspect of the present invention is as described above. Therefore, the matters explained in the section regarding the annuloplasty ring according to the second aspect of the present invention (including the annuloplasty ring according to the first aspect of the present invention, if necessary) can be referred to as appropriate.
[0068] [Step 1 according to the second aspect of the present invention] Step 1 according to the second aspect of the present invention is a step of providing a fabric or material on the outside of a ring-shaped core to obtain a composite of the ring-shaped core and the fabric or material.
[0069] Step 1 according to the second aspect of the present invention is carried out by first preparing the core according to the second aspect of the present invention. Specifically, for example, a commercially available stainless steel ring (e.g., stainless steel ring manufactured by Maruho Hatsujo Kogyo) is prepared and, if necessary, adjusted to the desired size. The core itself according to the second aspect of the present invention is as described above on the page regarding the annuloplasty ring according to the second aspect of the present invention, and specific examples and preferred examples thereof are also the same.
[0070] Step 1 according to the second aspect of the present invention, following the above, involves providing a fabric or material on the outer surface (surface) of the core according to the second aspect of the present invention. Specifically, the fabric or material is wrapped around the core according to the second aspect of the present invention and sewn or simply covered. The suturing method may be any method commonly used in this field, such as hand sewing or mechanical suturing using a sewing machine. When providing the second layer according to the second aspect of the present invention in the annuloplasty ring according to the second aspect of the present invention, step 1 is performed by providing the second layer according to the second aspect of the present invention on the outer surface (surface) of the core according to the second aspect of the present invention, and then providing a fabric or material on the outer surface (surface) of the second layer. Specific examples of the method in this case include covering the core according to the second aspect of the present invention with the second layer according to the second aspect of the present invention and sealing both ends with liquid silicone or the like, or preparing a mold larger than the core according to the second aspect of the present invention, inserting the core according to the second aspect of the present invention and the second layer into the mold, and molding them together. The second layer itself according to the second aspect of the present invention is as explained above on the page of the annuloplasty ring according to the second aspect of the present invention (including the annuloplasty ring according to the first aspect of the present invention, if necessary), and specific examples and preferred examples thereof are also the same. By Step 1 according to the second aspect of the present invention, a composite of a ring-shaped core and a fabric or cloth can be obtained.
[0071] [Step 2 according to the second aspect of the present invention] Step 2 according to the second aspect of the present invention is a step of contacting the composite obtained in Step 1 according to the second aspect of the present invention with a hydrogel to obtain a coated composite impregnated with a hydrogel.
[0072] The method for contacting the composite with the hydrogel can be carried out by a method commonly used in this field. Specifically, for example, the method described above in the section on the annuloplasty ring of the second aspect of the present invention (e.g., a method of spraying or applying a hydrogel) can be referenced. In step 2 of the second aspect of the present invention, a method using a mold may be employed in addition to or instead of the above method. A specific example of the method using a mold is a method in which the composite is fixed on the central axis of a container containing the hydrogel. This method allows the composite to be uniformly impregnated with the hydrogel. Specific examples of the shape of the container include a cylindrical shape and a prismatic shape such as a triangular prism, a square prism, or a pentagonal prism. In the method using a mold, the time for fixing the hydrogel is from several seconds to 24 hours, and the temperature during fixation is from 0°C to room temperature. After fixation, a drying period may be provided as needed. The hydrogel itself in step 2 according to the second aspect of the present invention is as explained above on the page for the annuloplasty ring according to the second aspect of the present invention (including the annuloplasty ring according to the first aspect of the present invention, if necessary), and specific examples, preferred examples, etc. are also the same. By step 2 according to the second aspect of the present invention, an impregnated composite impregnated with a hydrogel can be obtained.
[0073] [Step 3 According to the Second Aspect of the Present Invention] Step 3 according to the second aspect of the present invention is a step of contacting the impregnated composite obtained in Step 2 according to the second aspect of the present invention with a crosslinking agent. By carrying out Step 3 according to the second aspect of the present invention, the hydrogel itself in the annuloplasty ring according to the second aspect of the present invention is chemically crosslinked. The type of crosslinking agent and the crosslinking method are as explained above on the page for the annuloplasty ring according to the second aspect of the present invention (including the annuloplasty ring according to the first aspect of the present invention, if necessary), and specific examples and preferred examples thereof are also the same. By carrying out Steps 1 to 3 according to the second aspect of the present invention, an annuloplasty ring can be produced, which includes (1) a ring-shaped core and (2) a first layer covering the surface of the core, the first layer including a fabric or texture impregnated with hydrogel.
[0074] <Valvuloplasty kit according to the second aspect of the present invention> Specific examples, preferred examples, etc. of the valvuloplasty kit according to the second aspect of the present invention can be found on the page for the valvuloplasty kit according to the first aspect of the present invention described above.
[0075] <Annuloplasty ring according to a third aspect of the present invention> The annuloplasty ring according to a third aspect of the present invention is characterized by comprising: (1) a ring-shaped core; and (2) a first layer circumferentially covering the surface of the core, the first layer including an impregnated layer containing a fabric or material impregnated with hydrogel and a hydrogel layer made of hydrogel. Details of the annuloplasty ring according to the third aspect of the present invention are described below.
[0076] [Core According to the Third Aspect of the Present Invention] Specific examples and preferred examples of the core according to the third aspect of the present invention can be found in the page on the core according to the first aspect of the present invention.
[0077] [First Layer According to the Third Aspect of the Present Invention] The first layer according to the third aspect of the present invention circumferentially covers the surface of the core according to the third aspect of the present invention, and includes a first layer including an impregnated layer containing a fabric or material impregnated with hydrogel, and a hydrogel layer made of hydrogel. In the annuloplasty ring according to the third aspect of the present invention, the first layer according to the third aspect of the present invention, which has a specific structure, circumferentially covers the surface of the core according to the third aspect of the present invention, for example. As will be shown in the Examples below, stress concentration can be suppressed, and as a result, stability problems due to fatigue fracture can be overcome. Note that, as used herein, "circumferential" refers to the ring shape of the core according to the third aspect of the present invention, and "circumferential" is synonymous with "covering the entire ring (shape) of the core."
[0078] The fabric or cloth in the first layer according to the third aspect of the present invention is preferably biocompatible, and specific examples include biocompatible knitted fabrics and woven fabrics. Various warp and weft knitting structures can be used as knitted fabrics, with particularly suitable examples including double raschel knitted fabrics, plain knitted fabrics, rib knitted fabrics, tricot fabrics, and raschel knitted fabrics. For example, the density of the warp knitted fabric (in a state in which the bioabsorbable material has not been decomposed and absorbed) is preferably 20 courses / inch to 200 courses / inch and 20 wales / inch to 55 wales / inch. From the viewpoints of ease of suturing the fabric to biological tissue, water resistance, pinhole leakage, and anisotropy of the warp knitted fabric, it is more preferably 70 courses / inch to 110 courses / inch and 30 wales / inch to 45 wales / inch, and even more preferably 80 courses / inch to 100 courses / inch and 32 wales / inch to 42 wales / inch. As the woven fabric, plain weave, twill weave and satin weave can be used.
[0079] The fabric or cloth in the first layer according to the third aspect of the present invention is preferably composed of threads made of bioabsorbable and / or non-bioabsorbable materials. The threads made of bioabsorbable materials are not particularly limited as long as they are biocompatible and decompose, absorb, or disappear in the body over time. For specific details, see, for example, the page on the first layer according to the first aspect of the present invention.
[0080] The non-bioabsorbable material is not particularly limited as long as it is biocompatible and is not decomposed, absorbed, or lost in the body over time. Specifically, for example, the page on the first layer according to the first aspect of the present invention can be referred to.
[0081] The first layer according to the third aspect of the present invention includes an impregnated layer containing a fabric or material impregnated with a hydrogel, meaning that the fabric or material is impregnated with the hydrogel. Here, "impregnated" means, for example, that the hydrogel has soaked into the fabric or material, but it may also mean that the hydrogel simply covers (coats) the fabric or material. Specific examples of the hydrogel include the first layer according to the first aspect of the present invention.
[0082] The first layer according to the third aspect of the present invention includes a hydrogel layer made of hydrogel. The hydrogel in the hydrogel layer in the first layer according to the third aspect of the present invention refers to a layer made of hydrogel that does not impregnate the fabric or material when the fabric or material is brought into contact with the hydrogel, as described above in the impregnated layer in the first layer according to the third aspect of the present invention, and may also be expressed as a layer made of only hydrogel or a layer made substantially of only hydrogel. The hydrogel in the hydrogel layer is as described above in the impregnated layer, and specific examples and preferred examples thereof can be referenced.
[0083] The configurations and positional relationships of the impregnated layer and hydrogel layer of the first layer according to the third embodiment of the present invention include, for example, the following patterns: (Pattern 1) a pattern according to the third embodiment of the present invention in which the surface of the core is covered with an impregnated layer, and that surface is further covered with a hydrogel layer, (Pattern 2) a pattern according to the third embodiment of the present invention in which the surface of the core is covered with a hydrogel layer, and that surface is further covered with an impregnated layer, (Pattern 3) a pattern according to the third embodiment of the present invention in which, when the fabric or cloth and the hydrogel are in a simple covering relationship in the impregnated layer, the surface of the core is covered with a hydrogel layer, and that surface is further covered with a fabric or cloth, and that surface is further covered with a hydrogel, and (Pattern 4) a pattern according to the third embodiment of the present invention in which, when the fabric or cloth and the hydrogel are in a simple covering relationship in the impregnated layer, the surface of the core is covered with a fabric or cloth, and that surface is further covered with a hydrogel (including a hydrogel layer).
[0084] The thickness of the first layer according to the third aspect of the present invention can be appropriately set depending on the patient to whom the annuloplasty ring of the third aspect of the present invention is to be applied, and is, for example, 100 micrometers to 2000 micrometers, preferably 130 micrometers to 1000 micrometers, more preferably 150 micrometers to 800 micrometers, even more preferably 170 micrometers to 600 micrometers, and most preferably 200 to 450 micrometers.
[0085] [Second Layer According to the Third Aspect of the Present Invention] The annuloplasty ring according to the third aspect of the present invention may include, in addition to the core and first layer according to the third aspect of the present invention, a second layer containing rubber (hereinafter, sometimes abbreviated as the second layer according to the third aspect of the present invention). The second layer according to the third aspect of the present invention contains the rubber described below and is positioned between the core according to the third aspect of the present invention and the first layer according to the third aspect of the present invention. Specific examples and preferred examples of the second layer according to the third aspect of the present invention can be found on the page regarding the second layer according to the first aspect of the present invention.
[0086] [Stress of Hydrogel According to the Third Aspect of the Present Invention] The annuloplasty ring according to the third aspect of the present invention has the above-described structure, and the ratio of the stress of the hydrogel in the hydrogel layer before the hydrogel is subjected to a water absorption treatment to the stress of the hydrogel after the hydrogel is subjected to the water absorption treatment is, for example, 0.05 to 0.80, preferably 0.07 to 0.60, more preferably 0.07 to 0.50, and particularly preferably 0.07 to 0.46. In another aspect, the ratio may be 0.07 (±0.02) or 0.4 (±0.02).
[0087] The water absorption treatment is a treatment in which the hydrogel layer is left in a solution at 30°C to 50°C for 30 to 90 minutes. The temperature is preferably 37°C, the solution is preferably water, and the time for leaving it in the solution is preferably 60 minutes. Specific examples of such water include ultrapure water, pure water, deionized water, and purified water, with ultrapure water being preferred.
[0088] The above stress is expressed as the stress per unit area (mm 2 Stress generated per unit area (N / mm 2 ) and is sometimes referred to as stress intensity. The stress can be measured, for example, by measuring the thickness (film thickness) of a hydrogel sample using a predetermined testing machine (for example, EZ-SX, manufactured by Shimadzu Corporation). Specifically, a tensile jig (for example, a 500N screw-type flat-type gripper, manufactured by Shimadzu Corporation) is used to clamp the sample from above and below at a position 8.5 mm from the end, and the sample is displaced until it breaks, and the stress at the time of break is recorded (the speed is, for example, 200 mm / min). For other detailed measurement methods, please refer to the contents of the examples described below.
[0089] As will be shown in the Examples below, the annuloplasty ring of the third aspect of the present invention surprisingly exhibits a significant reduction in stress concentration by setting the above-mentioned specific ratio value, thereby overcoming the stability problem due to fatigue failure. The inventors first determined this parameter (ratio value) based on the finding that when the degree of crosslinking of the hydrogel is low, the hydrogel tends to become more fragile due to water absorption. Therefore, the inventors were the first to clarify the relationship between this parameter and the reduction in stress concentration. Therefore, it is preferable that the annuloplasty ring of the third aspect of the present invention has the above-mentioned specific ratio value.
[0090] The above ratio is calculated using the following formula: <Formula 2> Ratio = stress value after water absorption treatment / stress value before water absorption treatment
[0091] Regarding the configuration, materials, characteristics, etc. of the annuloplasty ring of the third aspect of the present invention, reference can be made to the items described in the annuloplasty ring of the first aspect of the present invention as appropriate.
[0092] <Method of Manufacturing an Annuloplasty Ring According to a Third Aspect of the Present Invention> The method of manufacturing an annuloplasty ring according to a third aspect of the present invention (hereinafter sometimes abbreviated as the manufacturing method according to the third aspect of the present invention) is a method of manufacturing an annuloplasty ring comprising the above-described (1) ring-shaped core and (2) a first layer circumferentially covering the surface of the core, the first layer comprising an impregnated layer comprising a fabric or material impregnated with hydrogel and a hydrogel layer comprising hydrogel, the method comprising: Step 1 (hereinafter sometimes abbreviated as step 1 according to the third aspect of the present invention) of providing the fabric or material on the outside of the ring-shaped core to obtain a composite of the ring-shaped core and the fabric or material; and Step 2 (hereinafter sometimes abbreviated as step 2 according to the third aspect of the present invention) of contacting the composite with hydrogel to obtain a first layer comprising an impregnated layer comprising a fabric or material impregnated with hydrogel and a hydrogel layer comprising hydrogel. It goes without saying that the annuloplasty ring manufactured by the manufacturing method according to the present invention is as described above. Therefore, the matters explained on the page regarding the annuloplasty ring according to the third aspect of the present invention can be referred to as appropriate.
[0093] [Step 1 according to the third aspect of the present invention] Step 1 according to the third aspect of the present invention is a step of providing a fabric or material on the outside of a ring-shaped core to obtain a composite of the ring-shaped core and the fabric or material.
[0094] Step 1 according to the third aspect of the present invention is carried out by first preparing the core according to the present invention. Specifically, for example, a commercially available stainless steel ring (e.g., stainless steel ring manufactured by Maruho Hatsujo Kogyo) is prepared and, if necessary, adjusted to the desired size. The core itself according to the third aspect of the present invention is as described above on the page regarding the annuloplasty ring according to the third aspect of the present invention, and specific examples and preferred examples thereof are also the same.
[0095] Step 1 according to the third aspect of the present invention, following the above, involves providing a fabric or material on the outer surface (surface) of the core according to the third aspect of the present invention. Specifically, the fabric or material is wrapped around the core according to the third aspect of the present invention and sewn or simply covered. The suturing method may be any method commonly used in this field, such as hand sewing or mechanical suturing using a sewing machine. When providing the second layer according to the third aspect of the present invention in the annuloplasty ring according to the third aspect of the present invention, step 1 is performed by providing the second layer according to the third aspect of the present invention on the outer surface (surface) of the core according to the third aspect of the present invention, and then providing a fabric or material on the outer surface of the second layer. Specific examples of the method in this case include covering the core according to the third aspect of the present invention with the second layer according to the third aspect of the present invention and sealing both ends with liquid silicone or the like, or preparing a mold larger than the core according to the third aspect of the present invention, inserting the core according to the third aspect of the present invention and the second layer thereinto, and molding them as a single unit. The second layer itself according to the third aspect of the present invention is as explained above on the page on the annuloplasty ring according to the third aspect of the present invention, and specific examples, preferred examples, etc. are also the same. By step 1 according to the third aspect of the present invention, a composite of a ring-shaped core and a fabric or cloth can be obtained.
[0096] [Step 2 according to the third aspect of the present invention] Step 2 according to the third aspect of the present invention is a step of obtaining a first layer including the composite obtained by Step 1 according to the third aspect of the present invention, an impregnated layer including a fabric or cloth impregnated with hydrogel, and a hydrogel layer made of hydrogel.
[0097] The method for contacting the composite with the hydrogel can be carried out by a method commonly used in this field. Specifically, for example, the method described in the section on the annuloplasty ring of the third aspect of the present invention (e.g., a method of spraying or applying a hydrogel) can be referenced. In step 2 of the third aspect of the present invention, a method using a mold may be employed in addition to or instead of the above method. A specific example of the method using a mold is a method in which the composite is fixed on the central axis of a container containing a hydrogel. This method allows the composite to be uniformly impregnated with the hydrogel. Specific examples of the shape of the container include a cylindrical shape and a prismatic shape such as a triangular prism, a square prism, or a pentagonal prism. In the method using a mold, the time for fixing the hydrogel is from several seconds to 24 hours, and the temperature during fixation is from 0°C to room temperature. After fixation, a drying period may be provided, if necessary. The hydrogel itself in step 2 according to the third aspect of the present invention is as explained above on the page for the annuloplasty ring according to the third aspect of the present invention, and specific examples, preferred examples, etc. are also the same. Step 2 according to the third aspect of the present invention described above makes it possible to obtain a first layer including an impregnated layer containing a fabric or material impregnated with hydrogel, and a hydrogel layer made of hydrogel.
[0098] In the manufacturing method of the third aspect of the present invention, a step of adding a crosslinking agent (hereinafter, sometimes abbreviated as step 3 according to the third aspect of the present invention) may be carried out subsequent to steps 1 and 2 according to the third aspect of the present invention. By carrying out step 3 according to the third aspect of the present invention, the hydrogel itself in the annuloplasty ring of the third aspect of the present invention is chemically crosslinked. The type of the crosslinking agent, the crosslinking method, etc. are as explained in the section on the annuloplasty ring of the third aspect of the present invention, and specific examples, preferred examples, etc. are also the same.
[0099] <Valvuloplasty kit according to the third aspect of the present invention> The valvuloplasty kit according to the third aspect of the present invention (hereinafter sometimes abbreviated as the kit according to the third aspect of the present invention) includes the annuloplasty ring according to the third aspect of the present invention and a holder and / or a sizer. For the annuloplasty ring according to the third aspect of the present invention, please refer to the page for the annuloplasty kit according to the first aspect of the present invention described above.
[0100] The present invention will be explained in more detail below with reference to examples, but the scope of the present invention is not limited to these examples.
[0101] Hereinafter, manufacturing examples, working examples and comparative examples relating to the annuloplasty ring according to the first aspect of the present invention will be described.
[0102] <Production Example 1: Production of the Annuloplasty Ring of the Present Invention> A stainless steel ring (manufactured by Maruho Hatsujo Kogyo, diameter 700 micrometers) was used as the core material. A silicone tube (manufactured by Silicone Techno) was placed around its outer periphery, and liquid silicone (TSE382-C, manufactured by Momentive Performance Materials Japan) was filled at both ends. The tube was then left to stand overnight at 50°C and sealed. A fabric (manufactured by Fukui Warp Knitting Co., Ltd.) with a density of 38-39 wales / inch and 90 courses / inch using polyethylene terephthalate yarn (33T15) was then wrapped around the outside and sutured (hereinafter, in this Production Example 1, this will be referred to as the "sample"). The sample was then immersed in Milli-Q and degassed at 50°C and 15 hPa or less for 30 minutes or more. The sample was then slowly immersed in a 9.5% w / w gelatin solution (manufactured by Nitta Gelatin; B-Matrix Gelatin LS-H) at 50°C and left to stand at 50°C. After 15 minutes, the sample was slowly removed and placed on a thread (Toray, Keiryu Tsurisei No. 0.1) with the sutured side facing up and allowed to stand. After 5 minutes, the sample was slowly immersed again in the gelatin solution, immediately slowly removed, and placed on the thread with the sutured side facing down and allowed to stand. After 5 minutes, the sample was slowly immersed again in the gelatin solution, immediately slowly removed, and placed on the thread with the sutured side facing up and allowed to stand. After 5 minutes, the sample was slowly immersed again in the gelatin solution, immediately slowly removed, and placed on the thread with the sutured side facing down and allowed to stand. After drying at room temperature for 30 minutes, the sample was immersed in 15 mL of 0.2% glutaraldehyde solution (Tokyo Chemical Industry, 50% glutaraldehyde solution) and allowed to react at room temperature for 3 hours. After the reaction, the sample was immersed in 15 mL of 60% glycerin water (Kenei Pharmaceutical, Pharmacopoeial Grade Glycerin) and allowed to stand at room temperature. After 30 minutes, the solution was replaced with fresh glycerin water. The above procedure was repeated twice. After the third glycerin wash, the sample was removed and dried overnight at room temperature to obtain an annuloplasty ring. The resulting annuloplasty ring was then placed in an aluminum bag containing a silica gel desiccant (Toyota Chemical Industries, Ltd., PC (White) 5G) and an oxygen scavenger (Oe Chemical Industry, Ltd., Tamotsu VX100) and irradiated with 30 kilograys of electron beams in the presence of dry ice (electron beam irradiation was outsourced to Sumitomo Heavy Industries Atex Co., Ltd.). This yielded an annuloplasty ring of the present invention.Other experimental conditions for the above electron beam irradiation are as follows: Irradiation device: electron beam irradiation device (e.g., Dynamitron electron accelerator manufactured by RDI) Dosimetry device: CTA dosimeter device (e.g., UV1800 spectrophotometer manufactured by Shimadzu) Dosimetry device: CTA dosimeter (e.g., FTR-125 manufactured by Fujifilm) Acceleration voltage: 4.8 megavolts Current: 20 milliamperes Cart speed (circumference): 18.0 m / min Irradiation direction: single-sided Number of irradiations: 2 Support material: cardboard laminate Other: Before electron beam irradiation, the dosimeter was used to measure the pre-irradiation absorbance. After electron beam irradiation, the dosimeter was removed and the post-irradiation absorbance was measured. The dose was calculated based on the difference in absorbance before and after irradiation.
[0103] <Production Example 2: Production of an annuloplasty ring of the present invention> An annuloplasty ring of the present invention was produced in the same manner as in Production Example 1, except that the glutaraldehyde concentration was changed to 0.05%.
[0104] <Production Example 3: Production of an annuloplasty ring of the present invention> An annuloplasty ring of the present invention was produced in the same manner as in Production Example 1, except that the glutaraldehyde concentration was changed to 1.5%.
[0105] <Production Example 4: Production of an annuloplasty ring> An annuloplasty ring was produced by wrapping a fabric made of polyethylene terephthalate around the core material described in Production Example 1.
[0106] <Production Example 5: Production of an annuloplasty ring> An annuloplasty ring similar to that described in Production Example 1 (but without electron beam irradiation) was produced.
[0107] Examples 1 to 3, Comparative Examples 1 and 2: Hemolysis Test Preparation of Samples for Hemolysis Test The annuloplasty rings of the present invention produced in Production Examples 1 to 3 and 5 were cut open with a scalpel into 7 mm x 10 mm sheets from the sutured surface. The cross sections of both ends were observed using a microscope (Keyence, VHX8000), and the thickness of the gelatin gel including the fabric at the apex was measured. The average value was taken as the thickness. Next, the pieces after the thickness measurement were placed on a 1 cm x 1 cm rubber sheet (As One, silicone rubber sheet, 1t 500mm square) with the silicone tube side facing down, and sewn with ETHIBOND 5-0 (registered trademark) (Johnson & Johnson) to prepare samples for the hemolysis test. An appropriate amount of silicone adhesive (TSE392W, manufactured by Momentive Performance Materials Japan) was applied to the backside of the sample, and the sample was fixed to the bottom of a polypropylene (PP) container (14 mL No. 4, manufactured by Maruemu) with the adhesive. Regarding the annuloplasty ring of Production Example 4, the film thickness was not measured, and a sample for the hemolysis test was prepared in the same manner as in Production Examples 1 to 3 and 5. Furthermore, a sample for the hemolysis test consisting of only the above silicone rubber was also prepared with reference to the above method.
[0108] [Preparation of Tube for Hemolysis Test] Pump tubing (3.2 x 6.4 cm high-strength roller pump silicone tubing, manufactured by AS ONE) was cut to a 45 cm length. Next, a pipette (2 mL pipette, manufactured by SUMILON) was cut to fit the 1.1 mL markings, and the cut 2 mL pipette was inserted into one end of the 45 cm tubing. To prevent blood from clogging due to pipette fragments, Milli-Q water was sucked from the nozzle using a metering pump (NRP-3000, manufactured by EYELA) and discharged from the silicone tubing side. Additionally, to check for nozzle defects, Milli-Q water was discharged from the silicone tubing side and discharged from the nozzle side. Tubes with defective nozzles were rejected, and for acceptable tubes, the water inside the tube was discharged and the tube was dried.
[0109] [Confirmation of Hemolysis] Hemolysis was confirmed for purchased blood (rabbit whole blood supplemented with sodium citrate, manufactured by Japan SLC). 10 mL of saline (500 mL plastic bottle, manufactured by Otsuka Pharmaceutical Factory) was placed in a centrifuge tube (15 mL polypropylene centrifuge tube, manufactured by Corning) and then 0.2 mL of blood was added. Centrifugation was performed at 750 × g for 5 minutes using a high-speed centrifuge (CF16RN, manufactured by Hitachi). For each sample, 200 μL of supernatant was added to three wells of a 96-well plate (96-well plate, manufactured by Violamo), and the optical density (OD) was measured (wavelength 576 nm) using a plate reader (SpectraMax190, manufactured by Molecular Devices Japan). OD values of all samples were confirmed to be 0.014 or less before use in the test.
[0110] [Confirmation of Flow Rate] The average flow rate was calculated from the amount of Milli-Q water discharged per 30 seconds using a metering pump and a tube and the diameter of the pipette, and the rotation speed was set so that the average flow rate was 7 m / sec.
[0111] [Preparation of negative and positive control blood samples] 600 μL of saline and 600 μL of blood were placed in a 1.5 mL tube (Hitec, low-protein-binding microtube, 1.5 mL) and incubated at 37°C for 70 minutes (this was the negative control). 600 μL of distilled water (Otsuka Pharmaceutical Factory, 500 mL plastic bottle) and 600 μL of blood were placed in a 1.5 mL tube and incubated at 37°C for 70 minutes (this was the positive control). The 1.5 mL tube was centrifuged at 800 × g for 5 minutes in a microcentrifuge (KUBOTA, Model 3740). For the negative control, 200 μL of supernatant was added to three wells of a 96-well plate. For the positive control, 180 μL of distilled water and 20 μL of supernatant were added to a 96-well plate for a 10-fold dilution (N=3). The OD was measured using a plate reader (wavelength 576 nm).
[0112] [Hemolysis Test] A metering pump was placed in a large incubator (Thermo, Model 3950) set to 38.5°C. 5 mL of saline was added to a 15 mL centrifuge tube, followed by 5 mL of blood to prepare 2x diluted blood, which was then warmed in a 37°C water bath for 10 minutes. The PP container was set vertically on a clamp, and the tube was attached to the metering pump so that the silicone tube side of the nozzle tube was in contact with the bottom of the PP container. When installed, the long axis of the sample was positioned toward the depth. The nozzle was fixed to a clamp set at a height of 3 mm vertically from the sample surface so that the jet velocity of the fluid ejected from the nozzle tip would be in the uniform velocity range (within 12 times the nozzle radius) and the blood would collide with the impact surface. A fixed amount of the warmed blood was transferred from the centrifuge tube to the PP container at a low rotation speed to prevent air from entering. Using an electric pipettor (Drummond, PipetteAid XP), the remaining blood in the centrifuge tube was transferred to a PP container. The blood was dispensed toward the sample for 1 hour at a rotation speed that resulted in a flow rate of 7 m / sec, determined during the prior flow rate check. After the test was completed, the entire blood was collected and stored in a 15 mL centrifuge tube. The centrifuge tube was centrifuged at 750 × g for 5 minutes in a high-speed centrifuge. 200 μL of supernatant per sample was added to three wells of a 96-well plate, and the OD was measured using a plate reader (wavelength 576 nm). If the supernatant had high absorbance, it was diluted appropriately and measured. The hemolysis rate was then calculated based on the following formula 3. <Equation 3> Hemolysis rate = (absorbance of target sample - absorbance of negative control) / (absorbance of positive control - absorbance of negative control) - (absorbance of sample consisting of silicone rubber only - absorbance of negative control) / (absorbance of positive control - absorbance of negative control) After testing for all samples was completed, the average flow rate was calculated from the amount of Milli-Q dispensed per 30 seconds and the diameter of the pipette, and it was confirmed that the average flow rate had not changed significantly from the start.
[0113] [Hemolytic Test Results] As described above, the results of the hemolytic test using the hemolytic test samples derived from the annuloplasty rings of Production Examples 1 to 5 are shown in Table 1 below. For convenience, the results for the annuloplasty rings of Production Examples 1 to 3 are referred to as Examples 1 to 3, respectively, and the results for the annuloplasty rings of Production Examples 4 and 5 are referred to as Comparative Examples 1 and 2, respectively.
[0114]
[0115] As is clear from Table 1, when the annuloplasty rings of Production Examples 1 to 3, i.e., the annuloplasty rings of the present invention, were used, the hemolysis rates were 14% (Example 1), 15.6% (Example 2), and 23.6% (Example 3), respectively. On the other hand, when the annuloplasty rings of Production Examples 4 and 5 were used, the hemolysis rates were 120.5% (Comparative Example 1) and 42.3% (Comparative Example 2), respectively. These results demonstrate that the annuloplasty rings of the present invention can significantly suppress the hemolysis rate. In particular, comparing Example 1 with Comparative Example 2, it was surprisingly found that the hemolysis rate was significantly improved by electron beam irradiation. Furthermore, comparing Examples 1 and 2 with Example 3, it was found that the hemolysis rate was further improved by reducing the glutaraldehyde concentration (e.g., less than 1.5%). These results demonstrate that the annuloplasty rings of the present invention are extremely superior in terms of hemolysis rate.
[0116] Hereinafter, manufacturing examples, working examples and comparative examples relating to the annuloplasty ring according to the second aspect of the present invention will be described.
[0117] Example 6: Production of annuloplasty ring of the present invention: An 80 mm stainless steel wire (manufactured by Hikari Mall, 0.7 mm stainless steel wire) was used as the core material, and a silicone tube (manufactured by Silicone Techno) was placed around the outer periphery of the core material. A fabric (manufactured by Fukui Warp Knitting Co., Ltd.) made of polyethylene terephthalate yarn (manufactured by Teijin, 33T12) with a density of 38-39 wales / inch and 90 courses / inch was then wrapped around the outer periphery and sewn together (hereinafter, this is referred to as the "sample" in Example 6). Next, 10 mm of a 0.7 x 2.0 mm silicone tube (manufactured by Labolan) was attached to one end of the core material so that the fabric was centered over the core material. Then, 10 mm of a 2.0 x 4.0 mm silicone tube (manufactured by Labolan) and 10 mm of a 4.0 mm x 6.0 mm silicone tube (manufactured by Labolan) were attached on top of the fabric, and an 80 mm silicone tube (manufactured by Labolan) was attached on top of the fabric to prepare a mold. 1.2 mL to 1.4 mL of 9.5% w / w gelatin solution (B-Matrix Gelatin LS-H, manufactured by Nitta Gelatin) at 50°C was poured into the mold along with the sample. A silicone tube was attached to the opposite end of the mold and capped. After leaving the sample in a 4°C refrigerator for 30 to 60 minutes, the sample was removed from the refrigerator, and two incisions, spaced 5 mm to 7 mm apart, were made on the side of the silicone tube using a scalpel. The incised portion was torn and the silicone tube was removed. The removed sample was immersed in 0.05% glutaraldehyde solution (Tokyo Kasei, 50% glutaraldehyde solution) and allowed to react at room temperature for 3 hours. After the reaction, the sample was immersed in 60% glycerin water (Kenei Pharmaceutical, Pharmacopoeial Grade Glycerin) and left to stand at room temperature. After 30 minutes, the solution was replaced with fresh glycerin water. This procedure was carried out twice, and after the third washing with glycerin water, the sample was taken out and dried at room temperature overnight to obtain the annuloplasty ring of the present invention.
[0118] <Production Example 7: Production of an annuloplasty ring of the present invention> An annuloplasty ring of the present invention was produced in the same manner as in Production Example 6, except that the glutaraldehyde concentration was changed to 0.5%.
[0119] <Production Example 8: Production of annuloplasty ring of the present invention> An 80 mm stainless steel wire (manufactured by Hikari Mall, stainless steel wire 0.7 mm) was used as the core material, and a silicone tube (manufactured by Silicone Techno) was placed around the outer periphery. A fabric (manufactured by Fukui Warp Knitting Co., Ltd.) made of polyethylene terephthalate yarn (manufactured by Teijin, 33T12) with a density of 38-39 wales / inch and 90 courses / inch was then wrapped around the outer periphery and sutured (hereinafter, in this Production Example 8, this is referred to as the "sample"). The sample was then slowly immersed in a 9.5% w / w gelatin solution (manufactured by Nitta Gelatin; B-Matrix Gelatin LS-H) at 50°C and allowed to stand at 50°C for at least 15 minutes. The sample was then slowly removed and allowed to stand at room temperature, allowing the fabric portion to float. After 5 minutes, the sample was slowly immersed again in the gelatin solution, immediately removed, and allowed to stand at room temperature for at least 30 minutes. Next, a 10mm piece of 0.7 x 2.0mm silicone tubing (manufactured by Labolan) was attached to one end of the core material so that the fabric was centered in the core material. A 10mm piece of 2.0 x 4.0mm silicone tubing (manufactured by Labolan) and a 4.0mm x 6.0mm silicone tubing (manufactured by Labolan) were attached on top of that, and an 80mm piece of 6.0 x 8.0mm silicone tubing (manufactured by Labolan) was then attached on top of that to prepare a mold. 1.2mL to 1.4mL of a 9.5% w / w gelatin solution (manufactured by Nitta Gelatin, B-Matrix Gelatin LS-H) at 50°C was poured into the mold along with the sample, and the silicone tubing was attached to the opposite end of the mold and capped. After leaving the sample in a 4°C refrigerator for 30 to 60 minutes, the sample was removed from the refrigerator, and two incisions were made on the side of the silicone tubing, spaced 5mm to 7mm apart, using a scalpel. The incised portion was torn and the silicone tubing was removed. The removed sample was immersed in a 0.2% glutaraldehyde solution (Tokyo Chemical Industry Co., Ltd., 50% glutaraldehyde solution) and allowed to react at room temperature for 3 hours. After the reaction, the sample was immersed in a 60% glycerin solution (Kenei Pharmaceutical Co., Ltd., official-grade glycerin) and allowed to stand at room temperature. After 30 minutes, the solution was replaced with fresh glycerin solution. This procedure was repeated twice, and after the third wash with glycerin solution, the sample was removed and dried at room temperature overnight to obtain an annuloplasty ring of the present invention.
[0120] <Preparation Example 9: Preparation of an annuloplasty ring> An annuloplasty ring was prepared by wrapping a fabric made of polyethylene terephthalate around the core material described in Preparation Example 6.
[0121] <Production Example 10: Production of an annuloplasty ring> An annuloplasty ring was produced by wrapping a fabric made of polyethylene terephthalate around the core material described in Production Example 6, and then wrapping a silicone tube around the outer periphery of the fabric.
[0122] <Measurement of Arithmetic Mean Roughness Ratio> The annuloplasty rings of the present invention manufactured in Production Examples 6 to 8 and 10 were cut into test pieces of 4 mm or more, and both sides of the samples were colored with a color spray (Color Spray ZERO, manufactured by Shinto Family) and dried. Next, using a one-shot 3D shape measuring instrument (VR-6000, manufactured by Keyence Corporation), the arithmetic mean roughness of the front and back surfaces of the annuloplasty rings of the present invention was measured within a 4 mm range (detailed conditions are as follows). Specifically, the annuloplasty rings were straightened and the arithmetic mean roughness was measured within a 4 mm range at three locations: both ends and the center. Here, in Production Examples 6 to 8, the surface referred to here is the surface of the hydrogel-impregnated fabric (corresponding to the first layer in the second aspect of the present invention), which does not come into contact with the silicone tube (corresponding to the second layer in the second aspect of the present invention). The back surface refers to the back surface of the hydrogel-impregnated fabric (corresponding to the first layer according to the second aspect of the present invention) that comes into contact with the silicone tube (corresponding to the second layer according to the second aspect of the present invention). Meanwhile, in Production Example 10, the front surface refers to the front surface of the silicone tube that does not come into contact with the fabric made of polyethylene terephthalate. The back surface refers to the back surface of the silicone tube that comes into contact with the fabric made of polyethylene terephthalate. Next, the ratio of the arithmetic mean roughness of the front surface to the back surface was calculated based on the following formula 4. <Formula 4> Arithmetic mean roughness ratio value = Arithmetic mean roughness value of the front surface of the first layer according to the second aspect of the present invention / Arithmetic mean roughness value of the back surface of the first layer according to the second aspect of the present invention. Measurement conditions: Roughness standard: JIS B 0601:1994, 2001 Cutoff value: 0.8 mm Reference value: 4 mm
[0123] <Measurement of Flexibility in the Out-of-Plane Direction> The annuloplasty rings of the present invention manufactured in Manufacturing Examples 6 to 8 and the annuloplasty rings manufactured in Manufacturing Examples 9 and 10 were placed in a low-temperature, constant-temperature, constant-humidity chamber set at 37°C and 80% RH for at least 24 hours to swell, and the flexibility improvement rate was evaluated using a small benchtop testing machine (Shimadzu Corporation, EZ-SX). Specifically, each annuloplasty ring was placed on a jig (Akimoto Koki), placed on a compression table, and pressed in the compression direction at the center with a 1 cm diameter compression rod. The load at a displacement of 1.07 mm was recorded (speed: 2.5 mm / min). The obtained load value was then used to evaluate the flexibility improvement rate of each annuloplasty ring in the out-of-plane direction. Here, as described above, this measurement system measured the force (load) required to move (displace) the annuloplasty ring 1.07 mm. This is based on the fact that out-of-plane movement of the annulus corresponds to a 1.07 mm movement (displacement) of the annulus (reference literature; J Anatomy, 2020; 237: 209-224). Therefore, the load (force) at a 1.07 mm displacement was measured using the above-described measurement, and it can be concluded that the lower the value, the better the flexibility in the out-of-plane direction. More specifically, the evaluation method used the load value of the annuloplasty ring of Manufacturing Example 9, which has the simplest configuration, as a reference, and evaluated the improvement in flexibility in the out-of-plane direction by dividing the load values of the annuloplasty rings of Manufacturing Examples 6 to 8 and 10 by the load value of the annuloplasty ring of Manufacturing Example 9. For example, if the load value of the annuloplasty ring of Manufacturing Example 9 is 1.0 and the load value of the annuloplasty ring of Manufacturing Example 6 is 0.7, then the load value of the annuloplasty ring of Manufacturing Example 6, 0.7, is 70% of the load value of the annuloplasty ring of Manufacturing Example 9, 1.0. Based on this calculation result, the flexibility improvement rate in the out-of-plane direction of the annuloplasty ring of Manufacturing Example 6 is evaluated to be 30% (100% - 70%). Therefore, it can be said that the higher the value (%) indicating this flexibility improvement rate, the better the flexibility in the out-of-plane direction.
[0124] <Measurement of gelatin solubility> The solubility of gelatin was measured for each of the annuloplasty rings produced in Production Examples 6 to 9. Specifically, for each of the gelatins used in Production Examples 6 to 9, a gelatin film was prepared, and the film was left in an aqueous solution at 37°C for 1 hour, and the state of the film was visually observed to measure the solubility.
[0125] <Summary of Evaluation Results> The results regarding the arithmetic mean roughness ratio, flexibility in the out-of-plane direction, and gelatin solubility using the annuloplasty rings of Production Examples 6 to 10 are shown in Table 2 below. For convenience, the results regarding the annuloplasty rings of Production Examples 6 to 8 are referred to as Examples 4 to 6, respectively, and the results regarding the annuloplasty rings of Production Examples 9 and 10 are referred to as Comparative Examples 3 and 4, respectively.
[0126]
[0127] As is clear from Table 2 above, the annuloplasty rings of Examples 6 to 8 exhibited values (%) indicating the improvement in flexibility in the out-of-plane direction of 30% (Example 4), 11% (Example 5), and 19% (Example 6), and the arithmetic mean roughness ratios were 0.09 (Example 4), 0.04 (Example 5), and 0.14 (Example 6), respectively. On the other hand, the annuloplasty ring of Comparative Example 4 exhibited a value (%) indicating the improvement in flexibility in the out-of-plane direction of 5%, and the arithmetic mean roughness ratio was 1.33. Therefore, it was found that annuloplasty rings having a specific arithmetic mean roughness ratio (e.g., 0.04 to 0.14), as in Examples 4 to 6, exhibited improved flexibility in the out-of-plane direction. Furthermore, while the rings exhibited flexibility, they also exhibited stability, as gelatin did not dissolve in the rings. Furthermore, when Examples 4 and 6 are compared with Example 5, it is found that flexibility is further improved by setting the ratio of arithmetic mean roughness to 0.09 (Example 4) to 0.14 (Example 6) (Example 4: 30%, Example 6: 19%, and Example 5: 11%). In particular, it is found that flexibility is most improved (30%) by setting the ratio of arithmetic mean roughness to 0.09 (Example 4).
[0128] The above results demonstrate that the annuloplasty ring of the present invention is extremely superior in terms of flexibility in the out-of-plane direction. When an annuloplasty ring has good flexibility in the out-of-plane direction, it can follow the natural movement of the annuloplasty ring during use, further reducing the risk of detachment between the annuloplasty ring and biological tissue. Therefore, the annuloplasty ring of the present invention, which possesses this flexibility, can be said to make a significant contribution to this technical field. It is anticipated that the annuloplasty rings of Examples 4 to 6 will achieve similar results to those described above even if they are subjected to electron beam irradiation as in Examples 1 to 3 above.
[0129] Hereinafter, manufacturing examples, working examples and comparative examples relating to the annuloplasty ring according to the third aspect of the present invention will be described.
[0130] <Production Example 11: Production of Gelatin Sheet> A release film (Purex, Teijin DuPont Films) and a stainless steel frame (Akimoto Koki) were placed in a styrofoam square case (Model 5, AS ONE). A 9.5% w / w gelatin solution (B-Matrix Gelatin LS-H, Nitta Gelatin) and the styrofoam square case were preheated to 65°C, and 5 mL of gelatin was added dropwise to the stainless steel frame until uniform. If the gelatin was not uniform, the lid was replaced and the sample was allowed to stand at 65°C until dissolved. The gelatin was then dried at room temperature for 30 minutes. The dried sample was immersed in 0.05% glutaraldehyde (Tokyo Chemical Industry Co., Ltd.) and allowed to react at room temperature for 3 hours. After the reaction, the sample was immersed in 60% glycerin water (Pharmacopoeial grade glycerin, Kenei Pharmaceutical Co., Ltd.) and allowed to stand at room temperature. After 30 minutes, the solution was replaced with fresh glycerin water. This operation was carried out twice, and after the third washing with glycerin water, the sample was taken out and dried in a vacuum to obtain a gelatin sheet.
[0131] <Production Example 12: Production of gelatin sheet> A gelatin sheet was produced in the same manner as in Production Example 11, except that the glutaraldehyde concentration was changed to 0.2%.
[0132] <Production Example 13: Production of gelatin sheet> A gelatin sheet was produced in the same manner as in Production Example 11, except that the glutaraldehyde concentration was changed to 0.3%.
[0133] <Production Example 14: Production of gelatin sheet> A gelatin sheet was produced in the same manner as in Production Example 11, except that the glutaraldehyde concentration was changed to 0.5%.
[0134] <Stress Measurement> The gelatin sheets produced in Production Examples 11 to 14 were punched out using a dumbbell-shaped No. 8 punching blade (for convenience, the punched gelatin sheets may be referred to as test pieces). Next, the thickness of the test pieces at three points, the top, middle and bottom, before and after the water absorption treatment was measured using a film thickness meter (Mitutoyo, VL-50), and the average value of these was taken as the film thickness of the sample. Thereafter, the stress of each gelatin sheet before and after the water absorption treatment was evaluated using a small benchtop testing machine (Shimadzu Corporation, EZ-SX). Here, the water absorption treatment is a treatment in which the gelatin sheet is left in ultrapure water at 37°C for 60 minutes. The stress is measured per unit area (mm 2 The maximum stress (N) is the stress per unit area (N / s) of the specimen. The specimen was clamped between a tensile jig (Shimadzu Corporation, 500N screw-type flat-type gripper) at positions 8.5 mm from the end of the specimen, and the specimen was displaced until it broke, measuring the maximum stress (speed: 200 mm / min). The stress ratio before and after the water absorption treatment was then calculated based on the following formula 5: <Formula 5> Stress ratio value = Stress value of the specimen after the water absorption treatment / Stress value of the specimen before the water absorption treatment. A silicone rubber sheet (hereinafter sometimes referred to as Production Example 15) was separately prepared, and the stress and its ratio before and after the water absorption treatment were measured using the same procedures as above. The measured values are summarized in Table 3 below.
[0135]
[0136] Evaluation of von Mises Stress The von Mises stress was evaluated for each of the annuloplasty rings containing gelatin derived from the gelatin sheets of Production Examples 11 to 14 as one of their constituent elements, the annuloplasty rings containing the structure of Production Example 5 as one of their constituent elements, and the annuloplasty rings containing polyethylene terephthalate (PET) as one of their constituent elements. The specific evaluation method is as follows. von Mises stress is a stress that indicates the stress state occurring inside an object with a single value, and is a scalar quantity with no direction. It is commonly used in this field for product performance evaluation, etc. Furthermore, since the von Mises stress can be determined by computer simulation, the following annuloplasty ring models were modeled on a computer, and the von Mises stress was calculated for each.
[0137] [Creating an annuloplasty ring model] (1) Obtaining S-S curves The S-S curves (sometimes referred to as stress-strain curves) of the components of the annuloplasty ring model described in (2) below, namely, cobalt alloy, silicone rubber, PET cloth, gelatin cross-linked with 0.05% glutaraldehyde, gelatin cross-linked with 0.2% glutaraldehyde, gelatin cross-linked with 0.3% glutaraldehyde, and gelatin cross-linked with 0.5% glutaraldehyde, were obtained with reference to JIS standards (JIS L1096:2010, JIS K6251:2017, JIS Z2241). These S-S curves were obtained to reflect the relationship between stress and strain, which is a mechanical property specific to each component, when constructing the model described in (2) below and calculating the von Mises stress by simulation. In addition, for cobalt alloy (Poisson's ratio: 0.332, Young's modulus: 199,391), silicone rubber (Poisson's ratio: 0.499, Young's modulus: 2.660), and PET cloth (Poisson's ratio: 0.499, Young's modulus: 2.947), the obtained S-S curves were approximately linear, so they were reflected in the model construction described below as linear materials. On the other hand, for gelatin, the S-S curve was nonlinear, so curve fitting was performed using a hyperelastic body model (Yeoh model) and then reflected in the model construction described below. The hyperelastic body model is a strain energy density function commonly used in the analysis of hyperelastic bodies and is known to be able to accurately approximate a wide range of strain (for example, JP 2021-131330 A, JP 2012-185042 A, etc.).
[0138] (2) Model Construction The following annuloplasty ring models 1 to 6 were created. Note that the following models 1 to 4 each have the gelatin of Production Examples 11 to 14 as their constituent elements. Model 5 has the silicone rubber sheet of Production Example 15 as its constituent element. Model 6 has PET cloth as its constituent element. Note that each model was constructed using commercially available software, Marc Mentat 2021.1.Model 1: Cobalt alloy (diameter 0.7 mm) as the core according to the present invention, silicone rubber (diameter 2.0 mm, thickness 0.65 mm) as the second layer according to the present invention, and PET cloth (diameter 2.4 mm, thickness 0.2 mm) coated with gelatin (0.05% glutaraldehyde crosslinked) (diameter 2.84 mm, thickness 0.22 mm) as the first layer according to the present invention. Model 2: Cobalt alloy (diameter 0.7 mm) as the core according to the present invention, silicone rubber (diameter 2.0 mm, thickness 0.65 mm) as the second layer according to the present invention, and PET cloth (diameter 2.4 mm, thickness 0.2 mm) coated with gelatin (0.2% glutaraldehyde crosslinked) (diameter 2.84 mm, thickness 0.22 mm) as the first layer according to the present invention. Model 3: A core of a cobalt alloy (diameter 0.7 mm) according to the present invention, a second layer of silicone rubber (diameter 2.0 mm, thickness 0.65 mm) according to the present invention, and a first layer of a PET cloth (diameter 2.4 mm, thickness 0.2 mm) coated with gelatin (0.3% glutaraldehyde cross-linked) (diameter 2.84 mm, thickness 0.22 mm) according to the present invention. Model 4: A core of a cobalt alloy (diameter 0.7 mm) according to the present invention, a second layer of silicone rubber (diameter 2.0 mm, thickness 0.65 mm) according to the present invention, and a first layer of a PET cloth (diameter 2.4 mm, thickness 0.2 mm) coated with gelatin (0.5% glutaraldehyde cross-linked) (diameter 2.84 mm, thickness 0.22 mm) according to the present invention. Model 5: Cobalt alloy (diameter 0.7 mm) as the core according to the present invention, silicone rubber (diameter 2.0 mm, thickness 0.65 mm) as the second layer according to the present invention, and PET cloth (diameter 2.4 mm, thickness 0.2 mm) coated with silicone rubber (diameter 2.84 mm, thickness 0.22 mm) as the first layer according to the present invention. Model 6: Cobalt alloy (diameter 0.7 mm) as the core according to the present invention, silicone rubber (diameter 2.0 mm, thickness 0.65 mm) as the second layer according to the present invention, and PET cloth (diameter 2.4 mm, thickness 0.2 mm) as the first layer according to the present invention.
[0139] [Calculation of von Mises stress] (1) Fixing jig The fixing jig was treated as a rigid body, and deformation of the fixing jig when deforming the annuloplasty ring was not taken into consideration. Here, the fixing jig refers to a container used in measurements described below, and is a cubic container measuring 8 mm x 8 mm x 8 mm.
[0140] (2) Calculation Conditions Figure 4 shows a schematic diagram of the analytical model used to calculate the von Mises stress for Models 1 to 6 (Figure 4 shows the annuloplasty ring 1, the X-axis direction 7, and the fixing jig 8, respectively). In this analytical model, the von Mises stress was evaluated when the fixing part fixed by the fixing jig was moved 2.55 mm in the X-axis direction (commercially available software, Marc Mentat 2021.1, was used to calculate the von Mises stress). To reduce the computational load on the computer, the calculation was performed using a half-symmetric model equivalent to the schematic diagram in Figure 4. Furthermore, since the fixing jig was treated as a rigid body (deformation of the fixing jig was not taken into account), instead of modeling the fixing jig, the same displacement as the fixing jig was applied to the contact surface of the annuloplasty ring with the fixing jig. In this measurement, the von Mises stress was calculated when the fixing part was moved 2.55 mm in the X-axis direction. This is based on the fact that movement of the annulus in the X-axis direction (i.e., the in-plane direction) corresponds to a movement (displacement) of 1.7 mm of the annulus (Reference: The Journal of Thoracic and Cardiovascular Surgery ? Volume 122, Number 4 666-673). Therefore, the von Mises stress required for a 1.7 mm displacement is calculated using the above calculation. The lower this value, the smaller the force acting on the annuloplasty ring due to the in-plane movement, resulting in a lower likelihood of damage to the annuloplasty ring. Note that, as mentioned above, the actual calculation was performed using 2.55 mm, which is the result of multiplying 1.7 mm by the safety factor of 1.5. The in-plane direction refers to the direction of arrow 3 in FIG. 3 , and its antonym, the out-of-plane direction, refers to the direction of arrow 2 in FIG. 3 .
[0141] [Calculation results] The von Mises stress (maximum value) calculated as described above is shown in Table 4. The location where the von Mises stress is maximum is the boundary of the fixed part, regardless of whether gelatin is present or not, and is thought to be influenced by the change in boundary conditions. Excluding the boundary of the fixed part, the von Mises stress was high in the center (the symmetry plane of the analytical model).
[0142]
[0143] [Note] As mentioned above, the Mises stress is calculated on a computer due to its characteristics. The calculation results are likely to be accurate because they are commonly performed in this field, but the validity of the calculation results may be verified from another perspective. For example, the following methods may be used for verification, but they are not limited to these.
[0144] (1) Advance Preparation: For example, annuloplasty rings identical to Model 6 and Models 1 to 4 are prepared. For details of the method, please refer to the contents of the present specification. Next, markings are made on both the left and right sides of the ring at a position 8 mm from the tip. Separately, cable covers (manufactured by SANWA, CA-KK22) are cut to 1.2 cm. The cut cable covers are arranged at 10.5 mm intervals, and epoxy resin putty is filled inside the cable covers. Next, each of the above annuloplasty rings is placed in epoxy resin putty up to a position 8 mm from the tip, and left to harden overnight.
[0145] (2) Measurement Using a 3D shot (Keyence, VR-6000), the diameter of each annuloplasty ring was measured at a position 8 mm from the marked tip.
[0146] (3) Tensile Test Using a small benchtop testing machine (Shimadzu Corporation, EZ-SX), the sample was displaced by a predetermined yield strain (e.g., speed: 2.5 mm / min). After displacement, the diameter was measured again 8 mm from the tip using a 3D shot. The deformation of each annuloplasty ring before and after displacement was calculated. The predetermined yield strain value can be set, for example, to a value equal to or greater than the yield strain measured when calculating the above-mentioned von Mises stress. Next, the deformation of the annuloplasty rings of Models 1 to 4 was compared with that of the annuloplasty ring of Model 6 to calculate the degree of deformation. This calculation result was then compared with the degree of deformation estimated from the above-mentioned yield strain measurement results, and the results were confirmed to show a consistent trend. In this example, the above verification was performed, and the trends were consistent, confirming the validity of the von Mises stress calculation system.
[0147] <Evaluation of Number of Times to Fatigue Failure> The von Mises stress calculated as above was substituted into the Elgiloy SN curve (http: / / www.hightechalloys.eu / pdf / Elgiloy_Flyer.pdf), which is commonly used in this field, to calculate the number of times to fatigue failure for each model, as shown in Table 5. The SN curve is a curve that shows the relationship between the stress applied repeatedly at a certain amplitude and the number of load cycles until fracture in the fatigue failure of a material. The number of times to fatigue failure refers to the number of cycles required for a sample to break. Therefore, the higher the number of times to fatigue failure, the more cycles the annuloplasty ring must be subjected to before it breaks, and therefore the stronger it is.
[0148]
[0149] <Summary of Evaluation Results> As is clear from Tables 4 and 5, the annuloplasty rings of Models 1 to 4, i.e., the annuloplasty rings containing gelatin as one of their components in Production Examples 11 to 14, which had stress ratios of 0.07 to 0.6, had significantly lower von Mises stresses than the annuloplasty rings of Models 5 and 6. That is, the annuloplasty rings of Models 1 to 4 reduced the stresses on the annuloplasty ring caused by in-plane movement of the annuloplasty ring (i.e., suppressed stress concentration), thereby reducing the likelihood of breakage of the annuloplasty ring. Among these, when comparing Models 1 to 3 (Production Examples 11 to 13) with Model 4 (Production Example 14), Models 1 to 3 (Production Examples 11 to 13) were found to have lower von Mises stresses. In particular, Model 1 (Production Example 11) had significantly lower von Mises stresses than the other models, making it the most superior model in terms of reducing the likelihood of breakage.
[0150] Furthermore, as is clear from Table 5, the use of the annuloplasty rings of Models 1 to 4, i.e., the annuloplasty rings containing gelatin of Production Examples 1 to 4, which have stress ratios of 0.07 to 0.6 as one of their constituent elements, significantly increased the number of fatigue failures compared to Models 5 and 6. In other words, the annuloplasty rings of Models 1 to 4 (Production Examples 11 to 14), which contain gelatin as one of their constituent elements, were found to have a significantly lower likelihood of failure even after repeated use. It is anticipated that the annuloplasty rings of Models 1 to 4 would achieve similar results to those described above even if they were subjected to electron beam irradiation as in Examples 1 to 3 above.
[0151] The annuloplasty ring of the present invention (e.g., the annuloplasty ring of the first aspect of the present invention) has improved hemolysis suppression effect and biocompatibility compared to conventional products, and can reduce the risk of reoperation due to hemolysis occurring after surgery. Therefore, it can be used in the annuloplasty ring manufacturing industry.
Claims
1. An annuloplasty ring comprising: (1) a ring-shaped core; and (2) a first layer covering the surface of the core, the first layer comprising a fabric or texture impregnated with a hydrogel, wherein the hydrogel is crosslinked by irradiation.
2. The annuloplasty ring according to claim 1, wherein (3) a second layer containing rubber is present between the core and the first layer, and the ratio of the arithmetic mean roughness of the surface of the first layer that is not in contact with the core or the second layer to the arithmetic mean roughness of the back surface of the first layer that is in contact with the core or the second layer is 0.01 to 0.
40.
3. The annuloplasty ring according to claim 1, wherein the first layer comprises an impregnated layer comprising a fabric or material impregnated with hydrogel, and a hydrogel layer made of hydrogel, the ratio of the stress of the hydrogel in the hydrogel layer before subjecting the hydrogel to a water absorption treatment to the stress of the hydrogel after subjecting the hydrogel to the water absorption treatment being 0.05 to 0.80, and the water absorption treatment being a treatment in which the hydrogel layer is left in a solution at 30°C to 50°C for 30 to 90 minutes.
4. The annuloplasty ring according to any one of claims 1 to 3, wherein the hydrogel is gelatin or collagen.
5. The annuloplasty ring according to claim 1, wherein the irradiation in the irradiation crosslinking is at least one selected from the group consisting of X-ray irradiation, gamma ray irradiation, electron beam irradiation, UV irradiation and plasma irradiation.
6. The annuloplasty ring according to claim 5, wherein the irradiation in the irradiation crosslinking is electron beam irradiation.
7. The annuloplasty ring of claim 1, wherein said fabric or material comprises polyester fibers.
8. The annuloplasty ring of claim 1, wherein said hydrogel is further chemically crosslinked.
9. An annuloplasty ring comprising: (1) a ring-shaped core; and (2) a first layer comprising a fabric or material impregnated with a hydrogel, the first layer covering the surface of the core.
10. The annuloplasty ring according to claim 1, which is used to suppress hemolysis in annuloplasty.
11. A kit for annuloplasty comprising the annuloplasty ring according to claim 1 and a holder and / or a sizer.
12. A method for manufacturing an annuloplasty ring comprising (1) a ring-shaped core and (2) a first layer comprising a fabric or material impregnated with a hydrogel, covering the surface of the core, the method comprising a step of irradiating the annuloplasty ring with radiation.
13. The method according to claim 12, wherein the step of irradiating with radiation is a step of irradiating with at least one selected from the group consisting of X-rays, gamma rays, electron beams, UV rays and plasma.
14. The method according to claim 13, wherein the step of irradiating with radiation is a step of irradiating with an electron beam.
15. The method of claim 12, further comprising the step of adding a cross-linking agent.
Citation Information
Patent Citations
A flexible valve ring forming ring selectively
JP1992503318A
Simulation method and material parameter identification method
JP2012185042A
A valvuloplasty ring for receiving a replacement valve
JP2018519895A
Asymmetric mitral annuloplasty band
JP2018519986A
Laminate and packaging bag
JP2020157516A
